
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E481DE8AEECAE30581DE003F6EC00A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="acsbmcau">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="ACS Bio &amp; Med Chem Au">
<meta name="citation_title" content="Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects">
<meta name="citation_author" content="László Galgóczy">
<meta name="citation_author_institution" content="Department of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged 6726, Hungary">
<meta name="citation_publication_date" content="2025 Jul 2">
<meta name="citation_volume" content="5">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="531">
<meta name="citation_doi" content="10.1021/acsbiomedchemau.5c00103">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/pdf/bg5c00103.pdf">
<meta name="description" content="The prevalence of fungal infections and contamination has increased alarmingly over the past decade, posing a significant threat to human health and the food supply and negatively affecting welfare. This escalating concern is primarily attributed to ...">
<meta name="og:title" content="Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The prevalence of fungal infections and contamination has increased alarmingly over the past decade, posing a significant threat to human health and the food supply and negatively affecting welfare. This escalating concern is primarily attributed to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371507">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1021/acsbiomedchemau.5c00103"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/bg5c00103.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371507%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371507/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371507/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-acsbmcau.png" alt="ACS Bio &amp; Med Chem Au logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to ACS Bio &amp; Med Chem Au" title="Link to ACS Bio &amp; Med Chem Au" shape="default" href="https://pubs.acs.org/journal/abmcb8" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">ACS Bio Med Chem Au</button></div>. 2025 Jul 2;5(4):531–552. doi: <a href="https://doi.org/10.1021/acsbiomedchemau.5c00103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1021/acsbiomedchemau.5c00103</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22ACS%20Bio%20Med%20Chem%20Au%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Overcoming
Global Antifungal Challenges: Medical and
Agricultural Aspects</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galg%C3%B3czy%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">László Galgóczy</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">László Galgóczy</span></h3>
<div class="p">
<sup>1</sup>
Department of Biotechnology
and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged
6726, Hungary
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galg%C3%B3czy%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">László Galgóczy</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Department of Biotechnology
and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged
6726, Hungary
</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">
Email: <span>galgoczi@bio.u-szeged.hu</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 22; Accepted 2025 Jun 20; Revised 2025 Jun 19; Collection date 2025 Aug 20.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author. Published by American Chemical Society</div>
<p>This article is licensed under CC-BY 4.0</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371507</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The prevalence of fungal infections and contamination
has increased
alarmingly over the past decade, posing a significant threat to human
health and the food supply and negatively affecting welfare. This
escalating concern is primarily attributed to the lack of safe, effective,
and widely available antifungal agents; the increasing spread of (multi)­drug
resistance to conventional antifungal treatments; and substantial
epidemiological shifts in fungal pathogens. Decision-making bodies
have recognized the urgency of this situation and prioritized efforts
to address and mitigate the spread of drug-resistant fungal infections
by developing and implementing innovative antifungal strategies, including
using drug combinations, designing fundamentally new antifungal compounds
with fungus-specific mechanisms of action and a minimal risk of resistance
development, drug repurposing, and exploring alternative approaches,
such as biomolecules, nanotechnology, and biological control. This
review aims to provide a comprehensive overview of the current challenges
associated with fungal infections in medicine and agriculture as well
as the latest advancements and potential solutions.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> human pathogenic fungus, phytopathogenic fungus, antifungal drug, fungicide, antifungal therapy, plant pathogenic fungi management, resistance, drug development</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/78eb56ad5084/bg5c00103_0009.jpg" loading="lazy" height="357" width="661" alt="graphic file with name bg5c00103_0009.jpg"></p></section><section class="abstract" id="abstract3"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/78eb56ad5084/bg5c00103_0007.jpg" loading="lazy" id="tgr1" height="357" width="661" alt="graphic file with name bg5c00103_0007.jpg"></p></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>The incidence of fungal
infections and damage caused by fungi has
recently reached alarming levels, and it has become evident that fundamentally
different treatment and preventive strategies from those currently
in use are necessary for both medicine and agriculture.
</p>
<p>Epidemiological survey data have revealed
a significant increase
in fatal human infections caused by drug-resistant fungi over the
past 2 decades, mainly among immunosuppressed patients.<em>
,
</em> The results from a 2020 survey suggested that of the approximately
150 million severe fungal infections that occur annually, around 1.7
million result in death, while a more
recent study in 2024 estimated this number to be as high as 3.8 million. Although some authors argue that the mortality
rate may be under- or overestimated due to irregular and unreliable
epidemiological surveys, the evidence suggests that fatal fungal infections
have doubled within just a few years. This
is attributed to epidemiological changes, the increasing number of immunosuppressed patients, and the decreasing
number of effective antifungal drugs. Fungi
generally cause non-life-threatening but difficult-to-treat mycoses
in immunocompetent individuals, mainly affecting the skin and mucosal
surfaces. However, in immunosuppressed patients, these superficial
infections may become invasive and involve the entire body, with a
high rate of mortality. The lack of effective
antifungal agents hampers the treatment of invasive fungal infections.
Furthermore, those currently available may cause severe side effects
in cases of prolonged therapy, permanently damaging organs of patients
due to the similarities in cell structure, function, and metabolism
to fungal cells. In clinical practice,
the most critical challenge is the increasing resistance of fungi
to one or more antifungal drugs with different mechanisms of action. Despite these troubling facts, this issue had
received limited attention, prompting the scientific community to
push for solutions at the policymaking level. To address this concern and raise public awareness, the World Health
Organization (WHO) released its first statement on the issue of fungal
infections in 2022, with the publication of the WHO fungal priority
pathogens list (FPPL) to guide research, development, and public health
action. This statement lists the 19 fungal pathogens posing the most
significant public health risk and highlights research (<a href="#tbl1" class="usa-link">Table 
</a>), development, and action goals.
It emphasizes the urgent need to prevent and control the spread of
fungal infections and their resistance to antifungal drugs by introducing
innovative strategies based on fundamentally different antifungal
agents with novel fungus-specific mechanisms of action.<em>
,
</em>
</p>
<section class="tw xbox font-sm" id="tbl1"><h3 class="obj_head">1. 19 Fungal Pathogens Posing the Most
Significant Public Health Risk and Highlights Research
.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">critical
group</th>
<th align="center" colspan="1" rowspan="1">high group</th>
<th align="center" colspan="1" rowspan="1">medium group</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" align="left" colspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> (formerly )</td>
<td align="left" colspan="1" rowspan="1">
<em>Scedosporium</em> spp.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Histoplasma</em> spp.</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> (formerly )</td>
<td align="left" colspan="1" rowspan="1">Eumycetoma causative
agents</td>
<td align="left" colspan="1" rowspan="1">
<em>Coccidioides</em> spp.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Mucorales</td>
<td align="left" colspan="1" rowspan="1"> (formerly )</td>
</tr>
<tr>
<td rowspan="4" align="left" colspan="1"> </td>
<td align="left" colspan="1" rowspan="1">
<em>Fusarium</em> spp.</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">
<em>Paracoccidioides</em> spp.</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Preventing and treating fungal infections poses a
tremendous challenge
not only for healthcare but also for
agriculture. The amount of pre- (in-field) and postharvest (under
storage) damage caused by plant pathogenic fungi has shown a steady
global increase in recent years, resulting in losses of billions of
dollars. Surveys have reported that 10–23% of annual crop yields
are lost in the field, while an additional 10–20% is wasted
due to fungal damage during storage. The economic losses pale in comparison
with their impact on ensuring a food supply for the growing global
population. If this loss is considered in relation to the five most
important crops for human nutrition (i.e., rice, wheat, maize, soybean,
and potato), it could otherwise feed 600 million to 4 billion people
annually, providing 2000 calories per person per day. The global population is estimated to reach 10 billion
by 2050, requiring at least a 60% increase from the current food produced
annually. Reducing the amount of food
damaged by fungi is one aspect of the solution to overcome the global
food problem and can be achieved by implementing appropriate and novel
preventive and management strategies.<em>
,
</em> However, the
current chemical fungicide-based approaches are inadequate because
plant pathogenic fungi have developed resistance, facilitating global
spread. Besides monoculture farming,
another reason for the spread of resistance is climate change, which
results in the emergence of pesticide-resistant plant pathogenic fungi
in agricultural areas, where they were previously absent. The spread
is further accelerated by global trade expansion and intensification,
facilitating the introduction of resistant plant pathogenic fungal
strains to new agricultural areas. The
problem has been further compounded in Europe by withdrawing and banning
effective chemical fungicides from commercial use under the current
European Union (EU) legislation on plant protection products. Moreover, the EU’s action plan (Toward
Zero Pollution for Air, Water and Soil), aimed at reducing the environmental
burden of chemical pesticides, mandates a 50% reduction in chemical
pesticides in Europe by 2030. Collectively,
these factors warrant the development of fungicides with a low environmental
impact and minimal risk of resistance development in plant pathogenic
fungi.
</p>
<p>This review provides a comprehensive
picture of the current state
and challenges of antifungal therapies and agricultural fungal pest
management of the above-mentioned aspects, with a particular focus
on insights gained over the past 5 years. Furthermore, it discusses
novel developments and solutions to overcome these recently emerging
antifungal issues.</p></section><section id="sec2"><h2 class="pmc_sec_title">2. Antifungal Therapy</h2>
<p>The severity of
the issues associated with currently used antifungal
agents for therapeutic purposes is demonstrated by the numerous highly
cited review articles published in recent years and over the past
decade, highlighting the challenges involved in the development of
new antifungal drugs.<em>
−








</em>
</p>
<p>The treatment of fungal infections in humans currently relies
on
five antifungal drug classes (polyenes, azoles, allylamines, echinocandins,
and others), each possessing different mechanisms of action, with
the majority directly or indirectly targeting the cell membrane or
cell wall (<a href="#tbl2" class="usa-link">Table 
</a>). For the treatment of non-life-threatening superficial
skin and toenail fungal infections that do not pose a significant
risk to healthy individuals, nearly all classes of antifungal drugs
are effective. Terbinafine, an allylamine antifungal, is widely used;
however, it is not employed for systemic infections as it primarily
accumulates in nails and hair. However,
in severe, life-threatening invasive mycoses, where fungal infections
affect the entire body, only azoles, polyenes, echinocandins, and
flucytosine remain suitable and are currently widely used. A significant limitation of flucytosine is the
high prevalence of resistance development, necessitating its use exclusively
in combination therapy with other antifungal agents rather than as
monotherapy.
</p>
<section class="tw xbox font-sm" id="tbl2"><h3 class="obj_head">2. Antifungal Drug Classes Commonly Used
for Treating Fungal Infections, Including Details of Their Targets,
Mechanisms of Action, and Most Frequently Applied Representatives.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">drug class</th>
<th align="center" colspan="1" rowspan="1">representative
agents</th>
<th align="center" colspan="1" rowspan="1">target</th>
<th align="center" colspan="1" rowspan="1">mechanism
of action</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">polyenes</td>
<td align="left" colspan="1" rowspan="1">amphotericin B, natamycin,
nystatin</td>
<td align="left" colspan="1" rowspan="1">cell membrane
(direct)</td>
<td align="left" colspan="1" rowspan="1">binds to
ergosterol, forming
pores in the fungal cell membrane, which leads to cell lysis</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">azoles</td>
<td align="left" colspan="1" rowspan="1">imidazoles: clotrimazole,
ketoconazole, luliconazole</td>
<td rowspan="2" align="left" colspan="1">cell membrane
(indirect)</td>
<td rowspan="2" align="left" colspan="1">inhibits ergosterol
biosynthesis by blocking lanosterol-14α-demethylase, compromising
membrane structure and integrity</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">triazoles: efinaconazole,
fluconazole, isavuconazole, itraconazole, posaconazole, voriconazole</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">allylamines</td>
<td align="left" colspan="1" rowspan="1">butenafine, naftifine, terbinafine</td>
<td align="left" colspan="1" rowspan="1">cell membrane (indirect)</td>
<td align="left" colspan="1" rowspan="1">inhibits ergosterol biosynthesis
by blocking the enzyme squalene epoxidase, damaging membrane formation
and generating toxic squalene byproducts</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">echinocandins</td>
<td align="left" colspan="1" rowspan="1">anidulafungin, caspofungin,
micafungin</td>
<td align="left" colspan="1" rowspan="1">cell wall
(indirect)</td>
<td align="left" colspan="1" rowspan="1">inhibits
1,3-β-<span class="font-variant-small-caps">d</span>-glucan synthesis by targeting 1,3-β-glucan
synthase,
compromising fungal cell wall formation</td>
</tr>
<tr>
<td rowspan="4" align="left" colspan="1">others</td>
<td align="left" colspan="1" rowspan="1">flucytosine</td>
<td align="left" colspan="1" rowspan="1">nucleic acid synthesis (indirect)</td>
<td align="left" colspan="1" rowspan="1">interferes with DNA and
RNA synthesis via its metabolic products</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">griseofulvin</td>
<td align="left" colspan="1" rowspan="1">cell division (direct)</td>
<td align="left" colspan="1" rowspan="1">binds to tubulin, disrupting
microtubule function and inhibiting fungal cell division</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ciclopirox</td>
<td align="left" colspan="1" rowspan="1">enzyme cofactors (direct)</td>
<td align="left" colspan="1" rowspan="1">chelates polyvalent metal
cations, inhibiting the function of enzymes vital for fungal cellular
activities</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">amorolfine</td>
<td align="left" colspan="1" rowspan="1">cell
membrane (indirect)</td>
<td align="left" colspan="1" rowspan="1">inhibits ergosterol biosynthesis
by targeting Δ14-sterol reductase and Δ7–Δ8-cholestenol isomerase, impairing membrane formation</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>From the 1950s to date, almost exclusively the same
early antifungal
drug groups (or modified versions) have been used in clinical practice
(<a href="#fig1" class="usa-link">Figure 
</a>).<em>
,
</em> Furthermore, over the past decade, only four new antifungal agents
(2018, superbioavailable itraconazole; 2021, ibrexafungerp; 2022, oteseconazole; and 2023, rezafungin) have been approved for therapeutic use. However, their mechanisms
of action and targets are the same as or similar to those of existing
antifungal agents, despite the continuously increasing incidence of
infections caused by fungal strains exhibiting resistance to such
mechanisms.
<a href="#tbl3" class="usa-link">Table 
</a> summarizes these newly introduced antifungal
agents and their mechanisms of action. <a href="#fig2" class="usa-link">Figure 
</a> presents the chemical structures of commonly
used antifungal drugs.</p>
<figure class="fig xbox font-sm" id="fig1"><h3 class="obj_head">1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371507_bg5c00103_0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/3f57217067f3/bg5c00103_0001.jpg" loading="lazy" id="gr1" height="258" width="700" alt="1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Timeline of antifungal agents approved by the United States
Food
and Drug Administration (FDA) for general therapeutic use and still
in use (up to March 2025). Since the 1950s, antifungal therapies have
mainly relied on early drug classes, such as azoles and polyenes or
their modified derivatives. Starting from the millennium, echinocandins
and ibrexafungerp have emerged as novel antifungal drug classes.<em>
,
</em> However, over the past decade, only four new antifungal agents (superbioavailable
itraconazole, ibrexafungerp, oteseconazole, and rezafungin) have been
introduced into therapeutic use. This appears counterproductive, because
these agents share similar mechanisms of action and targets, such
as the fungal cell membrane and cell wall, with existing therapies,
despite the increasing prevalence of fungal infections caused by strains
resistant to these mechanisms. 5FC: flucytosine,
AMB: amphotericin B, AMF: amorolfine, AFG: anidulafungin, BTF: butenafine,
CAS: caspofungin, CLT: clotrimazole, CPX: ciclopirox, EFI: efinaconazole,
FLC: fluconazole, GRF: griseofulvin, IBX: ibrexafungerp, ISA: isavuconazole,
ITC: itraconazole, KTC: ketoconazole, LUL: luliconazole, MFG: micafungin,
NFT: naftifine, NAT: natamycin, NYT: nystatin, OTE: oteseconazole,
POS: posaconazole, RZF: rezafungin, SUBA-ITC: superbioavailable itraconazole,
TRB: terbinafine, VRC: voriconazole. The figure is compiled using
information presented in Houšt’ et al., Carmo et al., and Zobi and
Algul and updated with the original literature
findings.</p></figcaption></figure><section class="tw xbox font-sm" id="tbl3"><h3 class="obj_head">3. Antifungal Agents Approved and Introduced
by the United States Food and Drug Administration (FDA) over the Past
Decade for Treating Fungal Infections.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">drug class</th>
<th align="center" colspan="1" rowspan="1">representative
agents</th>
<th align="center" colspan="1" rowspan="1">target</th>
<th align="center" colspan="1" rowspan="1">mechanism
of action</th>
<th align="center" colspan="1" rowspan="1">reference</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" align="left" colspan="1">azoles</td>
<td align="left" colspan="1" rowspan="1">triazoles: superbioavailable
itraconazole</td>
<td rowspan="2" align="left" colspan="1">cell membrane
(indirect)</td>
<td rowspan="2" align="left" colspan="1">inhibits ergosterol
biosynthesis by blocking lanosterol-14α-demethylase, compromising
membrane structure and integrity</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">tetrazoles:
oteseconazole</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">echinocandins</td>
<td align="left" colspan="1" rowspan="1">rezafungin</td>
<td rowspan="2" align="left" colspan="1">cell wall (indirect)</td>
<td rowspan="2" align="left" colspan="1">inhibits 1,3-β-<span class="font-variant-small-caps">d</span>-glucan synthesis by targeting 1,3-β-glucan synthase,
compromising fungal cell wall formation</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">others</td>
<td align="left" colspan="1" rowspan="1">(triterpenoid): ibrexafungerp</td>
<td align="left" colspan="1" rowspan="1">

</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="fig2"><h3 class="obj_head">2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371507_bg5c00103_0002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/e8a74e8701b6/bg5c00103_0002.jpg" loading="lazy" id="gr2" height="1203" width="772" alt="2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical structures of commonly used antifungal drugs.
Asterisks
indicate antifungal agents that have been approved for therapeutic
use in the past decade.</p></figcaption></figure><p>On one hand, the limited number of safe and effective
antifungal
agents with new mechanisms of action can be attributed to the lack
of interest from pharmaceutical companies. On the other hand, antifungal
drug development faces far more challenges than antibacterial drugs,
primarily due to the similarities in cell structure, function, and
metabolism between fungal and mammalian cells, making it extremely
challenging to identify fungal-specific targets.<em>
,
</em> Additionally, developing a new and effective antifungal therapeutic
agent must overcome numerous other challenges.</p>
<section id="sec2.1"><h3 class="pmc_sec_title">2.1. Recent Challenges of Antifungal Therapy</h3>
<p>Recent epidemiological studies have demonstrated that the effective
treatment of fungal infections can only be achieved by employing fundamentally
different strategies from those currently used. Such new antifungal therapeutic strategies must align with
the susceptibility profiles of newly emerging pathogens, resulting
from epidemiological changes. Thus, antifungal agents with novel mechanisms
of action must be effective against fungal biofilms, have a low risk
of resistance development, and possess fungal-specific mechanisms
to avoid severe side effects. Furthermore, these agents must exhibit
appropriate pharmacokinetic and pharmacodynamic properties to ensure
their suitability for treating invasive fungal infections. Other critical
requirements are relatively low production costs and accessibility
in the regions most affected by fungal infections, often the world’s
poorer countries.
</p>
<section id="sec2.1.1"><h4 class="pmc_sec_title">2.1.1. Epidemiological Changes</h4>
<p>The substantial
changes in the epidemiology of fungal infections in recent years are
complex and involve numerous underlying causes, such as climate change,
the prophylactic and improper use of antifungal agents, and the coronavirus
disease 2019 (COVID-19) pandemic. Changes in weather due to climate
change in recent years are some of the most striking manifestations
of global warming. Fungi are highly adaptable to gradually increasing
environmental temperatures, leading to the development of a thermotolerant
phenotype. Thermotolerance higher than that of the environment is
a virulence factor that renders previously nonpathogenic fungal species
infectious. Thus, changing environmental conditions may lead to the
spread of fungal species or their vectors to areas where they were
previously absent. Extreme weather associated with climate change
(i.e., flooding, storms, and hurricanes) significantly promotes the
emergence and spread of previously rare fungal infections. Examples
of newly emerging and more widely distributed fungal pathogens include , <em>Blastomyces</em> spp., (formerly ), , , <em>Histoplasma</em> spp., <em>Paracoccidioides</em> spp.,
and .
</p>
<p>The increasing use of prophylactic antifungal
treatments due to the growing number of immunocompromised and immunosuppressed
patients, combined with inadequate or unavailable identification techniques
and the agricultural use of antifungal agents that are also used in
medicine (such as triazoles), has disrupted the normal human mycoflora
and exerted selective pressure, resulting in the emergence of multidrug-resistant
strains. Consequently, the epidemiology of common fungal infections,
such as candidiasis and aspergillosis, has significantly changed over
the past 2 decades, with drug-resistant infections caused by non-albicans <em>Candida</em> species and cryptic <em>Aspergillus</em> species becoming increasingly common.
</p>
<p>The COVID-19 pandemic further amplified the above-mentioned
phenomena,
primarily due to the immunosuppressive effects of systemic corticosteroid
therapy in the treatment of COVID-19. During and after the pandemic,
there was a dramatic increase in infections caused by azole-resistant
cryptic <em>Aspergillus</em> strains, alongside a continued
rise in infections caused by non-albicans <em>Candida</em> species and a resurgence of . Some Asian countries, particularly India, reported a drastic increase
in mucormycosis (&gt;47,500 cases), which is caused by members of
the
order Mucorales, most of which were linked to COVID-19 infection and
systemic corticosteroid therapy.
</p>
<p>Combating the newly emerging fungal infections resulting from epidemiological
changes requires the development of effective antifungal therapies,
regular epidemiological surveys, resistance studies, and diagnostic
techniques capable of rapidly and effectively identifying newly emerging
species.
</p></section><section id="sec2.1.2"><h4 class="pmc_sec_title">2.1.2. Resistance, Biofilm Formation, and Tolerance</h4>
<p>Resistance to an antifungal agent can be either innate or acquired.
Innate resistance is associated with the general physiological characteristics
of the fungus, which may render it resistant to the mechanism of action
of a specific class of antifungal agents. Thus, even without any acquired
resistance mechanism, the sensitivity of individual fungal species
(or even different isolates of the same species) to specific antifungal
agents may vary. Acquired resistance is caused by epigenetic changes
or genomic mutations that alter a property compared with the wild
type, making it resistant to the mechanism of action of an antifungal
agent. Common causes of resistance development
include prolonged exposure to a suboptimal application of an antifungal
agent during clinical therapy or the
agricultural use of antifungal agents (such as triazoles) also used
in human medicine.
</p>
<p>It has been
established that infections caused by fungi resistant to one or more
antifungal agents are rapidly increasing.<em>
,
</em> However, recent studies have highlighted a significant rise in the
incidence of infections caused by triazole (fluconazole, itraconazole,
and voriconazole)-resistant , multidrug (amphotericin B, echinocandin, fluconazole, and flucytosine)-resistant (formerly ), and , and terbinafine-resistant dermatophytes (<em>Trichophyton</em> spp., <em>Microsporum</em> spp., and <em>Epidermophyton</em> spp.).<em>
,
</em> Acquired resistance to one antifungal agent
often leads to resistance to another, a phenomenon known as multidrug
resistance. A good recent example is the emergence of azole/echinocandin-resistant strains.
<a href="#fig3" class="usa-link">Figure 
</a> summarizes
the observed resistance mechanisms.</p>
<figure class="fig xbox font-sm" id="fig3"><h5 class="obj_head">3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371507_bg5c00103_0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/ea53ad034cde/bg5c00103_0003.jpg" loading="lazy" id="gr3" height="720" width="700" alt="3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mechanisms of action of antifungal drug
classes and the associated
principal forms of acquired resistance. (a) Polyene resistance: (1)
altered cell membrane permeability, (2) loss-of-function mutations
in ergosterol biosynthesis genes, (3) changes in membrane sterol composition,
and (4) induction of genes promoting tolerance and stress response
pathways. Mechanism of action (MA): formation of a polyene-ergosterol
complex, decreasing the protein gradient and resulting in osmotic
lysis. (b) Azole resistance: (1) point
mutations in the gene encoding the target (lanosterol 14α-demethylase),
(2) target overproduction, (3) efflux pump overproduction or hyperactivity,
(4) hypermutation in the target and housekeeping genes, and (5) heteroresistance
and aneuploidy. MA: lanosterol 14α-demethylase inhibition. (c) Pyrimidine analog resistance: (1) target
gene (cytosine deaminase and flucytosine resistance) mutations. MA:
RNA and DNA synthesis inhibition. (d)
Allylamine resistance: (1) target gene (squalene epoxidase) mutations,
(2) antifungal compound degradation, (3) efflux pump overproduction
or hyperactivity, and (4) induction of stress response pathways. MA:
squalene epoxidase inhibition. (e) Echinocandin
resistance: (1) point mutations in the gene encoding the target (1,3-β-glucan
synthase subunit [<em>FKS1</em>]) and (2) cell wall stress
response pathway activation. MA: 1,3-β-glucan synthase inhibition. (f) Triterpenoid resistance: (1) point mutations
in the gene encoding the target (1,3-β-glucan synthase subunit
[<em>FKS2</em>]) and (2) unknown responses to cell wall stress.
MA: 1,3-β-glucan synthase inhibition. 5-FU: 5-fluorouridine, CYP51A/ERG11: lanosterol 14α-demethylase, <em>ERG</em>: ergosterol biosynthesis genes, <em>FCY</em>: cytosine deaminase gene, <em>FCA</em>: flucytosine resistance
gene, FdUMP: 5′-fluoro deoxyuridine monophosphate, Fks1p and
Fks2p: 3-β-glucan synthase subunits, <em>FUR1</em>:
uracil phosphoribosyltransferase gene, <em>hsp</em>: heat
shock protein gene, Hsp90: heat shock protein 90, <em>MSH2</em>: azole resistance gene, <em>sal</em>A: salicylate 1-monooxygenase
gene SalA: salicylate 1-monooxygenase, <em>sqle</em>: squalene
epoxidase gene. Asterisks indicate mutations. The figure is adapted
from Fisher et al. and updated using
information presented in Martinez-Rossi et al., and with the original literature findings. Panels (a)–(f)
are adapted by permission from Macmillan Publishers Ltd.: NATURE REVIEWS
MICROBIOLOGY Fisher, M.C. et al. Tackling the emerging threat of antifungal
resistance to human health. <em>Nat</em>. <em>Rev</em>. <em>Microbiol</em>. <strong>2022</strong>, 20(9), 557–571,
copyright 2022.</p></figcaption></figure><p>Polyenes alter the cell membrane permeability by
forming complexes
with ergosterol. Typically, polyene resistance involves loss-of-function
mutations in genes involved in the ergosterol biosynthesis pathway,
particularly in <em>Aspergillus</em> and <em>Candida</em> species. In , the loss
of sterol C-5-desaturase (<em>ERG3</em>) and the upregulation
of sterol C-22-desaturase (<em>ERG5</em>), Δ(24)-sterol
C-methyltransferase (<em>ERG6</em>), and sterol C-4-methyl
oxidase (<em>ERG25</em>) commonly contribute to polyene resistance
(<a href="#fig3" class="usa-link">Figure 
</a>a). The resistance to amphotericin B is rare compared
to azoles and echinocandins due to the high fitness cost and the resulting
impairment of fungal growth, and reduced survival in host environments.<em>
,
</em>
</p>
<p>Azoles inhibit ergosterol biosynthesis by targeting lanosterol
14α-demethylase (<em>ERG11</em>), disrupting cell membrane
formation. Azole resistance is typically caused by efflux pump overexpression
in <em>Candida</em> species or lanosterol 14α-demethylase
mutations and promoter insertions affecting the sterol biosynthesis
pathway in <em>Aspergillus</em> species. In other species
such as , lanosterol
14α-demethylase overproduction, efflux pump overexpression,
and hypermutations are responsible for azole resistance. Additionally,
heteroresistance and aneuploidy further facilitate azole resistance
(<a href="#fig3" class="usa-link">Figure 
</a>b).
</p>
<p>Byproducts of pyrimidine analogue metabolism
inhibit DNA and RNA
synthesis. Resistance to these agents (e.g., flucytosine) mainly arises
from point mutations in the target gene cytosine deaminase (<em>FCY1</em>), particularly in <em>Candida</em> species,
and hypermutation is a frequent resistance mechanism in <em>Cryptococcus</em> species (<a href="#fig3" class="usa-link">Figure 
</a>c).
</p>
<p>Allylamines inhibit squalene
epoxidase, a key enzyme in the ergosterol
biosynthesis pathway, disrupting cell membrane formation. The inhibition
of squalene epoxidase leads to the accumulation of toxic squalene
byproducts that compromise organelle membrane integrity and ultimately
impair fungal viability, which is the primary antifungal mechanism
of allylamines. Resistance mechanisms (especially in <em>Trichophyton</em> spp.) include mutations in the squalene epoxidase gene, overproduction
of salicylate 1-monooxygenase capable of degrading allylamine, efflux
pump overexpression, and induction of membrane and stress response
pathways (<a href="#fig3" class="usa-link">Figure 
</a>d).
</p>
<p>Echinocandins and triterpenoids inhibit
1,3-β-glucan synthase,
preventing the synthesis of 1,3-β-<span class="font-variant-small-caps">d</span>-glucan, a cell
wall component.<em>
,
</em> Echinocandin resistance typically
results from mutations in 1,3-β-glucan synthase (<em>FKS1</em>), particularly in <em>Candida</em> and <em>Fusarium</em> species (<a href="#fig3" class="usa-link">Figure 
</a>e). Triterpenoid resistance is also
associated with mutations in 1,3-β-glucan synthase, specifically
impacting <em>FKS2</em> in (<a href="#fig3" class="usa-link">Figure 
</a>f). Stress response pathways, such as those involving
heat shock protein 90 (Hsp90), Ca<sup>2+</sup>/calcineurin signaling,
Ras GTPase-linked mechanisms, and the unfolded protein response, have
been implicated in echinocandin resistance (<a href="#fig3" class="usa-link">Figure 
</a>e). However,
the role of these pathways in triterpenoid resistance mechanisms has
yet to be fully elucidated (<a href="#fig3" class="usa-link">Figure 
</a>f).
</p>
<p>A notable factor
contributing to antifungal resistance is the biofilm-forming
properties of fungi. Most human pathogenic fungi form biofilms within
the human body or on medical devices and instruments. These comprise
a mass of fungal cells adhered to a surface and embedded in an extracellular
matrix of polymer compounds secreted by the fungi. Biofilm formation
begins with fungal cells or spores adhering to a living or inorganic
surface, followed by filamentous growth, interconnection, and secretion
of extracellular matrix materials, forming a protective barrier. This
matrix masks the fungal cells, providing extensive protection against
the host’s immune system and antifungal agents. This is further enhanced by increased efflux
pump activity within the biofilm, changes in antifungal targets within
fungal cells, and the effects of proteins associated with filamentation. In biofilm form, fungi sensitive in the planktonic
(yeast-like) state may become resistant to antifungal agents.
</p>
<p>These observations indicate the urgent
need for novel antifungal
agents with minimal risk of resistance development (or at least very
slow resistance development) and effectiveness against fungal biofilms.</p>
<p>Recent studies have shown that in addition to genetic resistance,
phenotypic resistance (antifungal drug tolerance) also affects the
therapeutic efficacy of antifungal drugs. Antifungal drug tolerance,
distinct from resistance, is characterized by the slow proliferation
of subpopulations that efficiently overcome antifungal stress. In , tolerance exhibits an inverse correlation
with intracellular drug accumulation and is mitigated by adjuvant
compounds administered alongside fluconazole, thereby enhancing therapeutic
efficacy in highly tolerant isolates. In , brain glucose induces
tolerance to amphotericin B via the glucose repression activator Mig1,
ultimately reducing treatment effectiveness in cryptococcal meningitis.
Mig1-driven tolerance mechanisms involve suppression of ergosterol
synthesis and augmented production of inositolphosphorylceramide,
which competes with amphotericin B for ergosterol binding. Co-administration
of amphotericin B with aureobasidin A, a fungal-specific inositolphosphorylceramide
synthase inhibitor, significantly enhances antifungal efficacy. Additionally, the develops fungicide-tolerant persisters in pulmonary infections enriched
in cells with high stationary-phase molecule production. The antioxidant
ergothioneine plays a crucial role in amphotericin B persistence,
indicating a conserved tolerance mechanism across diverse fungal species.
Sertraline demonstrates selective antifungal activity against amphotericin
B-tolerant persisters, suggesting a promising therapeutic avenue for
cryptococcosis. Understanding fungal
tolerance mechanisms can improve antifungal therapy strategies by
identifying new drug targets and optimizing combination treatments.</p></section><section id="sec2.1.3"><h4 class="pmc_sec_title">2.1.3. Safe and Effective Applicability</h4>
<p>The effective and safe application of an antifungal agent requires
a thorough understanding of its pharmacokinetic and pharmacodynamic
properties, which may vary among different classes of antifungal drugs.
Taking these into consideration, along with the susceptibility of
the pathogenic fungus to antifungal agents, certain antifungal drugs
are suitable for treating different types and localizations of fungal
infections. Severe side effects (mainly
kidney and liver damage) are prone to developing during the treatment
of invasive fungal infections, particularly prolonged intravenous
administration of antifungal agents such as polyenes, triazoles, and
flucytosine. Less severe side effects (e.g., arrhythmias and disorders
of the central nervous system, cardiovascular system, and respiratory
system) must also be considered for all antifungal drugs. Echinocandins
are currently considered the safest class of antifungal drugs. However, because they have significantly poorer
pharmacokinetic and pharmacodynamic properties when administered orally,
they are only available for intravenous use.
<a href="#tbl4" class="usa-link">Table 
</a> summarizes
the pharmacokinetic and pharmacodynamic properties of the antifungal
agents used to treat life-threatening invasive fungal infections.<em>
,−

</em>
</p>
<section class="tw xbox font-sm" id="tbl4"><h5 class="obj_head">4. Pharmacokinetic and Pharmacodynamic
Characteristics of the Antifungal Agents Commonly Used for Treating
Invasive Fungal Infections<sup></sup>
.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">drug class</th>
<th align="center" colspan="1" rowspan="1">application</th>
<th align="center" colspan="1" rowspan="1">pharmacokinetics</th>
<th align="center" colspan="1" rowspan="1">pharmacodynamics</th>
<th align="center" colspan="1" rowspan="1">central nervous
system penetration</th>
<th align="center" colspan="1" rowspan="1">key efficacy</th>
<th align="center" colspan="1" rowspan="1">serious side
effects</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="8" align="left" colspan="1">polyenes (amphotericin
B)</td>
<td align="left" colspan="1" rowspan="1">topical</td>
<td align="left" colspan="1" rowspan="1">bioavailability (oral administration):
low</td>
<td align="left" colspan="1" rowspan="1">concentration-dependent
antifungal effect: yes</td>
<td align="left" colspan="1" rowspan="1">cerebrospinal fluid: low</td>
<td rowspan="8" align="left" colspan="1">
<em>Aspergillus</em> spp., , <em>Candida</em> spp., , , , <em>Mucor</em> spp., <em>Rhodotorula</em> spp., </td>
<td rowspan="8" align="left" colspan="1">nephrotoxicity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">protein binding: high</td>
<td align="left" colspan="1" rowspan="1">prolonged post-antifungal
effect: yes</td>
<td rowspan="7" align="left" colspan="1">brain tissue:
low</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">intraperitoneal</td>
<td align="left" colspan="1" rowspan="1">metabolism (cytochrome P450):
none</td>
<td rowspan="6" align="left" colspan="1">efficacy: concentration-dependent</td>
</tr>
<tr>
<td rowspan="5" align="left" colspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">excretion (unmetabolized):
renal-low, hepatic-high</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">distribution: plasma, extracellular
fluids, outside the bloodstream</td></tr>
<tr><td align="left" colspan="1" rowspan="1">clearance: moderate</td></tr>
<tr><td align="left" colspan="1" rowspan="1">half-life: medium to long</td></tr>
<tr><td align="left" colspan="1" rowspan="1">time to maximum drug
concentration:
medium</td></tr>
<tr>
<td rowspan="8" align="left" colspan="1">triazoles (fluconazole,
itraconazole, posaconazole, voriconazole, isavuconazole)</td>
<td align="left" colspan="1" rowspan="1">topical</td>
<td align="left" colspan="1" rowspan="1">bioavailability (oral administration):
high</td>
<td align="left" colspan="1" rowspan="1">concentration-dependent
antifungal effect: no</td>
<td align="left" colspan="1" rowspan="1">cerebrospinal fluid (%):
low to high</td>
<td rowspan="8" align="left" colspan="1">
<em>Aspergillus</em> spp., , <em>Candida</em> spp., , , , , <em>Phaeohyphomycetes</em> spp., </td>
<td rowspan="8" align="left" colspan="1">hepatotoxicity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">protein binding: low to
high</td>
<td align="left" colspan="1" rowspan="1">prolonged post-antifungal
effect: yes</td>
<td rowspan="7" align="left" colspan="1">brain tissue
(%): high</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">intraperitoneal</td>
<td align="left" colspan="1" rowspan="1">metabolism (cytochrome P450):
yes or glucuronidation</td>
<td rowspan="6" align="left" colspan="1">efficacy: exposition
and minimum inhibitory concentration-dependent</td>
</tr>
<tr>
<td rowspan="5" align="left" colspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">excretion (unmetabolized):
renal-medium to high, hepatic-low to high</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">distribution: outside the
bloodstream</td></tr>
<tr><td align="left" colspan="1" rowspan="1">clearance: high</td></tr>
<tr><td align="left" colspan="1" rowspan="1">half-life: medium to long</td></tr>
<tr><td align="left" colspan="1" rowspan="1">time to maximum drug concentration:
short to medium</td></tr>
<tr>
<td rowspan="8" align="left" colspan="1">echinocandins
(anidulafungin, caspofungin, micafungin)</td>
<td rowspan="8" align="left" colspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">bioavailability (oral administration):
orally not administered</td>
<td align="left" colspan="1" rowspan="1">concentration-dependent
antifungal effect: yes</td>
<td align="left" colspan="1" rowspan="1">cerebrospinal fluid: low</td>
<td rowspan="8" align="left" colspan="1">
<em>Candida</em> spp.</td>
<td rowspan="8" align="left" colspan="1">not known</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">protein binding: high</td>
<td align="left" colspan="1" rowspan="1">prolonged post-antifungal
effect: yes</td>
<td rowspan="7" align="left" colspan="1">brain tissue:
low to medium</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">metabolism (cytochrome P450):
yes, spontaneous degradation, independent</td>
<td rowspan="6" align="left" colspan="1">efficacy: exposition
and (minimum inhibitory) concentration-dependent</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">excretion (unmetabolized):
renal-low, hepatic-low</td></tr>
<tr><td align="left" colspan="1" rowspan="1">distribution: plasma, extracellular
fluids, outside the bloodstream</td></tr>
<tr><td align="left" colspan="1" rowspan="1">clearance: high</td></tr>
<tr><td align="left" colspan="1" rowspan="1">half-life: medium to long</td></tr>
<tr><td align="left" colspan="1" rowspan="1">time to maximum drug concentration:
short to medium</td></tr>
<tr>
<td rowspan="8" align="left" colspan="1">flucytosine</td>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">bioavailability (oral administration):
high</td>
<td align="left" colspan="1" rowspan="1">concentration-dependent
antifungal effect: no</td>
<td align="left" colspan="1" rowspan="1">cerebrospinal fluid: high</td>
<td rowspan="8" align="left" colspan="1">
<em>Candida</em> spp., </td>
<td rowspan="8" align="left" colspan="1">nephrotoxicity,
hepatotoxicity, bone marrow damage</td>
</tr>
<tr>
<td rowspan="7" align="left" colspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">protein binding: low</td>
<td align="left" colspan="1" rowspan="1">prolonged post-antifungal
effect: no</td>
<td rowspan="7" align="left" colspan="1">brain tissue:
high</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">metabolism
(cytochrome P450):
minimal</td>
<td rowspan="6" align="left" colspan="1">efficacy: time-dependent</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">excretion (unmetabolized):
renal-high</td></tr>
<tr><td align="left" colspan="1" rowspan="1">distribution: plasma, extracellular
fluids</td></tr>
<tr><td align="left" colspan="1" rowspan="1">clearance: moderate</td></tr>
<tr><td align="left" colspan="1" rowspan="1">half-life: short</td></tr>
<tr><td align="left" colspan="1" rowspan="1">time to maximum drug concentration:
medium</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t4fn1">
<sup>a</sup><p class="display-inline">Compiled based on tables from Mazzei
and Novelli, Lepak and Andes, Carmo et al., and
Ashley.
</p>
</div></div></section><p>The effective treatment of central nervous system
fungal infections
is exceptionally challenging, mainly due to the limited penetration
of currently available antifungal agents across the blood–brain
barrier, which can be significantly improved using liposomal formulations
(e.g., amphotericin B) (<a href="#tbl4" class="usa-link">Table 
</a>). However, therapy remains unsuccessful in most cases, even
when the theoretically effective dose of the antifungal agent is predicted
to enter the central nervous system because traditional pharmacokinetic
principles are not universally applicable to the central nervous system.
Furthermore, altered physiology in immunosuppressed patients and the
use of other medications influence the pharmacokinetics and pharmacodynamics
of antifungal drugs.<em>
,
</em> Consequently, central nervous
system fungal infections are associated with high mortality rates
regardless of the pathogen, reaching 90–100% in immunosuppressed
patients.
</p>
<p>One of the causes of
the development of severe side effects is
the similarity in cell structure, function, and metabolism between
fungi and human hosts. Thus, the development of exclusively fungus-specific
antifungal agents is challenging. However, this problem could be solved
by identifying fungus-specific molecular targets. Some fungi enter
host cells, where they are less exposed to the effects of antifungal
agents and the immune system. Therefore, effective antifungal agents
or therapeutic approaches must have good cell penetration properties. These observations emphasize the urgent need
to develop small-molecule antifungal compounds capable of penetrating
the blood–brain barrier, ensuring both safe application and
predictable therapeutic efficacy.
</p></section><section id="sec2.1.4"><h4 class="pmc_sec_title">2.1.4. Cost and Availability</h4>
<p>Introducing
a compound with proven antifungal effects for clinical therapeutic
use is expensive and time-consuming. In 2015, it was estimated that
this process would take approximately 10 years and cost around $300
million in the United States, with an additional $400 million in marketing
expenses for commercial launch. Furthermore,
a 2020 study estimated that developing an entirely new drug (including
target identification and approval) would take 12–20 years,
costing approximately $1.8 billion. Considering
the rapid spread of resistance to currently used antifungal agents,
it is conceivable that these costs may never be recovered before the
drug becomes unsuitable for therapeutic use. Coupled with the current
estimate of only a 5% chance of newly developed antifungal molecules
passing the clinical testing phases, the interest of pharmaceutical
companies in developing and marketing new antifungal agents is limited.<em>
,
</em>
</p>
<p>The availability, cost, and therapy expenses of different
antifungal agents vary across countries. This disparity significantly affects the ability of middle- and,
most notably, low-income countries, which are the most heavily affected
regions in terms of life-threatening fungal infections, to effectively
combat fungal infections. A prime example
is the prohibitive cost and limited availability of liposomal amphotericin
B and flucytosine therapies in these countries. Furthermore, the lack of proper diagnostic knowledge and
tools, as well as mitigating surveys, contribute to the exceptionally
high number of fatal mycoses in these regions.<em>
,
</em> To alleviate this problem, policies must be implemented to ensure
that regardless of cost, the most effective antifungal agents and
diagnostic techniques are globally accessible. Moreover, strict guidelines
for effectively using antifungal agents must be established, requiring
a well-trained workforce of specialists.
</p></section></section><section id="sec2.2"><h3 class="pmc_sec_title">2.2. New Trends in Antifungal Therapy</h3>
<p>A potential solution to the antifungal problems is the combined use
of antifungal drugs using the simultaneous or sequential application
of two antifungal agents with distinct mechanisms of action and targets.
This approach reduces the risks of resistance development and side
effects, while synergistically enhancing each other’s efficacy
and broadening the antifungal spectrum. Over the past 3 decades, numerous drugs used to treat different
diseases have been shown to possess secondary antifungal effects beyond
their original indication, making them potentially useful as either
independent or adjuvant treatments. Repurposing such drugs for antifungal
application is cheaper and quicker than developing an entirely new
agent. Using drug databases to identify
targets suitable for fungus-specific antifungal therapy enables the
design of new drug molecules or drug repurposing, laying the groundwork
for safe, side-effect-free antifungal therapies in the future. Several promising candidate molecules possessing
novel antifungal mechanisms of action have already reached various
stages of clinical testing. However, they have yet to be introduced
for therapeutic use.
</p>
<section id="sec2.2.1"><h4 class="pmc_sec_title">2.2.1. Antifungal Drug Combinations</h4>
<p>The
interaction between two combined antifungal agents is either synergistic
(mutually enhancing each other’s efficacy), additive (equaling
the sum of their individual efficacies), or antagonistic (mutually
reducing each other’s efficacy). Synergy is favorable for achieving
a more effective antifungal treatment than monotherapy, but antagonism
should be avoided. Notably, the efficacy of an antifungal agent can
be enhanced not only by another antifungal drug but also by a drug
not known for its antifungal properties. Such an example is ibuprofen,
a nonsteroidal anti-inflammatory drug, which, despite lacking inherent
antifungal activity, synergistically increases the efficacy of fluconazole
against <em>Candida</em> infections by efflux pump inhibition.
A synergistic antifungal drug combination involves one of the following
underlying mechanisms: (1) one agent increases the biological availability
of the other, (2) the agents target different components of the same
biological pathway or different but interrelated pathways, or (3)
one agent suppresses the stress response induced by the other. An
example of the first mechanism is the interaction between amphotericin
B and flucytosine, where amphotericin B enhances membrane permeability,
facilitating the intracellular uptake of flucytosine. An example of
the second mechanism is the interaction between terbinafine and azoles,
where both target the ergosterol biosynthesis pathway but at different
points (<a href="#fig3" class="usa-link">Figure 
</a>b,d).
An example of the third mechanism is the combined application of Hsp90
inhibitors, which block the stress response to azoles. Because these
synergistic antifungal combinations, often only observed <em>in
vitro</em>, have the potential for therapeutic success, many new
methods have recently been developed to identify synergistic antifungal
drug combinations. In clinical practice,
the most frequently used drug combinations for therapeutic purposes
include amphotericin B + flucytosine/azoles or echinocandin + azoles
for invasive candidiasis, azoles/amphotericin B + echinocandin or
voriconazole + anidulafungin for invasive aspergillosis, and amphotericin
B + posaconazole/caspofungin for mucormycosis.
</p></section><section id="sec2.2.2"><h4 class="pmc_sec_title">2.2.2. Drug Repurposing</h4>
<p>Drug repurposing
involves identifying new therapeutic applications for commercially
available drugs beyond their original use. Such an approach offers
numerous advantages and may be the basis for a novel antifungal strategy.
Including commercial market authorization, this process only takes
3–12 years and costs approximately $50 million, a fraction
of the outlay required to develop an entirely new drug. Various <em>in vitro</em> and <em>in silico</em> techniques have identified numerous candidate
antifungal drug molecules from drug molecule databases, primarily
against <em>Candida</em> species.<em>
,,
</em> Potential candidates for repurposed antifungal
agents include various antibiotics, immunosuppressive drugs, cholesterol-lowering
statins, antiarrhythmic drugs, antipsychotics, antidepressants, and
nonsteroidal anti-inflammatory drugs. However, repurposed antifungal agents have several drawbacks: (1) <em>in vitro</em> antifungal activity does not guarantee <em>in vivo</em> efficacy, (2) therapeutically effective antifungal
doses may cause severe side effects, (3) low concentrations may lead
to resistance development, and (4) the exact mechanism of their antifungal
action is not always fully understood, hindering therapeutic applications.<em>
,,
</em> Nevertheless, even in unsuccessful
applications, these drugs may serve as templates for developing new
antifungal agents.
</p></section><section id="sec2.2.3"><h4 class="pmc_sec_title">2.2.3. Identification of Novel Fungal-Specific
Targets</h4>
<p>Developing a fundamentally new and safe antifungal
agent begins by identifying fungal-specific targets that differ from
those targeted by commercially available antifungals. These novel
targets enable the selective destruction of pathogenic fungi, potentially
reducing the risk of side effects in humans. Such novel fungus-specific targets may be components of pathways
already affected by commercially available antifungal agents (e.g.,
ergosterol biosynthesis and cell wall biosynthesis) that have yet
to be targeted or entirely new pathways. As mentioned earlier, newly
identified targets may also be used for drug repurposing. A major
advantage of developing new agents targeting components of pathways
already addressed by commercial antifungal agents is that drugs with
similar mechanisms of action have already shown effectiveness in clinical
settings, thereby increasing the likelihood of these new agents successfully
passing clinical testing phases. Newly
targeted pathways primarily include those involved in resistance development
(e.g., efflux pumps, lanosterol 14α-demethylase expression,
and Hsp90), virulence (e.g., biofilm formation and morphological changes),
respiration (mitochondria), and metabolism (e.g., various enzymes
of gluconeogenesis).<em>
,
</em> Pathways to consider from these
aspects include Hsp90-calcineurin-protein kinase C-linked pathways
(e.g., Hsp90-associated proteins and FK506-binding protein 12), Ras
GTPase signaling pathways (e.g., diaminobutyrate-2-oxoglutarate, aminotransferase,
and farnesyltransferase), other signaling pathways (MAP kinase, phosphoinositide-dependent
kinase, sphingosine 1-phosphate), the glyoxylate cycle (e.g., isocitrate
lyase and malate synthase), trivalent cation-linked pathways (e.g.,
polyketide synthase and siderophore synthase), the trehalose biosynthesis
pathway (e.g., trehalose-6-phosphate synthase), the lipid biosynthesis
pathway (e.g., ceramide synthase and serine palmitoyl transferase),
aspartate pathway and amino acids biosynthesis-related enzymes (e.g.,
acetohydroxyacid synthase, aspartate transaminase), pyrimidine pathway
(e.g., dihydroorotate dehydrogenase), and the respiratory chain (e.g.,
mitochondrial cytochrome bc1-reductase and cytochrome P450).<em>
,,
</em> Besides these, numerous other
potential targets are under consideration, including transcription
factors (e.g., sterol uptake control protein 2), ceramide synthase,
acetyltransferases (e.g., inositol acyltransferase), deacetylases
(e.g., histone deacetylases playing a role in heterochromatin remodelation),
and siderophores.<em>
,,
</em>
</p></section><section id="sec2.2.4"><h4 class="pmc_sec_title">2.2.4. Development of Entirely New Antifungal Drugs</h4>
<p>The first step in developing an entirely new antifungal drug involves
screening a broad molecular library for <em>in vitro</em> antifungal
activity followed by identifying its target fungal component. Then,
the molecule’s structure may be optimized to enhance its efficacy,
and it is tested in mammalian infection models. If proven effective
in these models, the drug undergoes phases of clinical testing, followed
by commercialization if it passes the trials.
<a href="#tbl5" class="usa-link">Table 
</a> provides
an overview of the antifungal agents developed to target components
of old and newly targeted biological pathways, which were still undergoing
clinical testing at the time of writing of this review (March 2025).
Thus, it is likely that many of these agents have now passed the final
clinical test phase and been approved and commercially launched, especially
those that are in the third phase of clinical trials focusing on the
effectiveness against existing treatments and monitoring the adverse
reactions. Entirely new antifungal agents in the third phase of clinical
trials include fosmanogepix, olorofim, chelated amphotericin B, albaconazole,
iodiconazole, and opelconazole. Fosmanogepix
inhibits glycosylphosphatidylinositol-linked cell wall transfer protein
1 (Gwt1), preventing essential changes required for cell survival.
This mechanism differs entirely from the previous antifungal drugs
used in clinical settings. Olorofim,
a dihydroorotate dehydrogenase inhibitor, disrupts pyrimidine biosynthesis
but is ineffective against <em>Candida</em> species. This
mechanism is also completely different from those of currently used
antifungal agents. Chelated amphotericin
B removes ergosterol from the cell membrane by binding to it and forming
aggregates. This formulation differs from existing amphotericin B
preparations because it achieves high bioavailability, even with oral
administration. Albaconazole, iodiconazole,
and opelconazole are new triazoles with a broader spectrum of antifungal
activity and stronger binding to lanosterol 14α-demethylase
than existing triazoles.<em>
,
</em>
<a href="#fig4" class="usa-link">Figure 
</a> presents the chemical structures of the
antifungal drugs under development.</p>
<section class="tw xbox font-sm" id="tbl5"><h5 class="obj_head">5. Antifungal Drugs under Development<sup></sup>
.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">drug class</th>
<th align="center" colspan="1" rowspan="1">drug</th>
<th align="center" colspan="1" rowspan="1">mechanism
of action</th>
<th align="center" colspan="1" rowspan="1">application</th>
<th align="center" colspan="1" rowspan="1">spectrum</th>
<th align="center" colspan="1" rowspan="1">advantages</th>
<th align="center" colspan="1" rowspan="1">clinical
trial phase</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">arylamidine</td>
<td align="left" colspan="1" rowspan="1">ATI-2307</td>
<td align="left" colspan="1" rowspan="1">inhibition of mitochondrial
complex III and IV enzymatic activity, decreasing ATP production</td>
<td align="left" colspan="1" rowspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., <em>Cryptococcus</em> spp., , </td>
<td align="left" colspan="1" rowspan="1">effective against all FPPL
pathogens, better bioavailability</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">depsipeptide</td>
<td align="left" colspan="1" rowspan="1">aureobasidin A</td>
<td align="left" colspan="1" rowspan="1">inhibition of inositol-phosphoceramide
synthase</td>
<td align="left" colspan="1" rowspan="1">oral, intravenous</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp.</td>
<td align="left" colspan="1" rowspan="1">broad antifungal spectrum</td>
<td align="left" colspan="1" rowspan="1">preclinical</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GPI inhibitor</td>
<td align="left" colspan="1" rowspan="1">fosmanogepix (APX001)</td>
<td align="left" colspan="1" rowspan="1">inhibition of GPI-anchored
cell wall transfer protein 1 (Gwt1)</td>
<td align="left" colspan="1" rowspan="1">oral, intravenous</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., <em>Coccidioides</em> spp., <em>Fusarium</em> spp., , <em>Scedosporium</em> spp.</td>
<td align="left" colspan="1" rowspan="1">effective against antifungal-resistant and strains</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">histone deacetylase
inhibitor</td>
<td align="left" colspan="1" rowspan="1">MGCD290</td>
<td align="left" colspan="1" rowspan="1">reduction of stress response
reactions through inhibition of histone deacetylase and Hsp90</td>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., <em>Fusarium</em> spp., <em>Mucor</em> spp., <em>Rhizopus</em> spp., <em>Rhodotorula</em> spp., <em>Trichosporon</em> spp., </td>
<td align="left" colspan="1" rowspan="1">synergistic interaction
with echinocandins and azoles</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">nucleoside peptide</td>
<td align="left" colspan="1" rowspan="1">nikkomycin Z</td>
<td align="left" colspan="1" rowspan="1">inhibition of type 1 chitin
synthase</td>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">, <em>Candida</em> spp., <em>Coccidioides</em> spp., , </td>
<td align="left" colspan="1" rowspan="1">synergistic interaction
with echinocandins and itraconazole against , , </td>
<td align="left" colspan="1" rowspan="1">phase I/II</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">orotomide</td>
<td align="left" colspan="1" rowspan="1">olorofim (F901318)</td>
<td align="left" colspan="1" rowspan="1">inhibition of pyrimidine
biosynthesis via dihydroorotate dehydrogenase inhibition</td>
<td align="left" colspan="1" rowspan="1">oral, intravenous</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., , <em>Coccidioides</em> spp., <em>Fusarium</em> spp., , , , <em>Penicillium</em> spp., , , , <em>Trichophyton</em> spp.</td>
<td align="left" colspan="1" rowspan="1">effective
against antifungal-resistant
fungi</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">polyene
(analog)</td>
<td align="left" colspan="1" rowspan="1">AM-2-19</td>
<td rowspan="3" align="left" colspan="1">removal of
ergosterol from the cell membrane via aggregation</td>
<td align="left" colspan="1" rowspan="1">nd</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., <em>Cryptococcus</em> spp., <em>Coccidioides</em> spp., </td>
<td align="left" colspan="1" rowspan="1">effective against amphotericin
B-resistant <em>Aspergillus</em> strains. Does not bind to
cholesterol</td>
<td align="left" colspan="1" rowspan="1">
<em>in vivo</em> experiments</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BSG005</td>
<td align="left" colspan="1" rowspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., <em>Cryptococcus</em> spp., <em>Mucor</em> spp., <em>Pneumocystis</em> spp.</td>
<td align="left" colspan="1" rowspan="1">fungicidal activity against
antifungal-resistant <em>Aspergillus</em> and <em>Candida</em> isolates. Less nephrotoxic than amphotericin B</td>
<td align="left" colspan="1" rowspan="1">phase I</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">chelated amphotericin B
(CAmB)</td>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Blastomyces</em> spp., <em>Candida</em> spp., <em>Coccidioides</em> spp., <em>Fusarium</em> spp., <em>Histoplasma</em> spp., <em>Paracoccidioides</em> spp., <em>Scedosporium</em> spp.</td>
<td align="left" colspan="1" rowspan="1">improved bioavailability</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">siderophore (analogue)</td>
<td align="left" colspan="1" rowspan="1">GR-2397 (ASP2397, VL-2397)</td>
<td align="left" colspan="1" rowspan="1">unknown, uptake through
Sit1 transporter</td>
<td align="left" colspan="1" rowspan="1">intravenous</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., , </td>
<td align="left" colspan="1" rowspan="1">effective against azole-resistant <em>Aspergillus</em> strains</td>
<td align="left" colspan="1" rowspan="1">phase II</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">tetrazole</td>
<td align="left" colspan="1" rowspan="1">quilsekonazole (VT-1129)</td>
<td rowspan="5" align="left" colspan="1">inhibition
of ergosterol biosynthesis via lanosterol 14α-demethylase inhibition</td>
<td rowspan="2" align="left" colspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">
<em>Candida</em> spp., <em>Coccidioides</em> spp.</td>
<td rowspan="2" align="left" colspan="1">specific for
fungal lanosterol 14α-demethylase</td>
<td align="left" colspan="1" rowspan="1">preclinical</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VT-1598</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., , <em>Candida</em> spp. <em>Coccidioides</em> spp., , , </td>
<td align="left" colspan="1" rowspan="1">phase I</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">triazole</td>
<td align="left" colspan="1" rowspan="1">albaconazole</td>
<td align="left" colspan="1" rowspan="1">oral</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., <em>Candida</em> spp., <em>Cryptococcus</em> spp., </td>
<td align="left" colspan="1" rowspan="1">broad antifungal
spectrum.
Good bioavailability</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">iodiconazole</td>
<td align="left" colspan="1" rowspan="1">topical</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp., dermatophyte species</td>
<td align="left" colspan="1" rowspan="1">broad antifungal spectrum.
High binding affinity to lanosterol 14α-demethylase</td>
<td align="left" colspan="1" rowspan="1">phase III</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">opelconazole</td>
<td align="left" colspan="1" rowspan="1">inhalation</td>
<td align="left" colspan="1" rowspan="1">
<em>Aspergillus</em> spp.</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t5fn1">
<sup>a</sup><p class="display-inline">ATP: adenosine triphosphate, FPPL:
fungal priority pathogens list, GPI:
glycosylphosphatidylinositol, Hsp90: heat shock protein 90, nd: no
data available. Compiled based on tables from Pfaller et al., Bouz and Doležal, Puumala et al., and Zobi and
Algul.
</p>
</div></div></section><figure class="fig xbox font-sm" id="fig4"><h5 class="obj_head">4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371507_bg5c00103_0004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/eebcfbd66051/bg5c00103_0004.jpg" loading="lazy" id="gr4" height="398" width="759" alt="4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical structures of antifungal drugs
under development.</p></figcaption></figure></section><section id="sec2.2.5"><h4 class="pmc_sec_title">2.2.5. Other Therapeutic Options (Biopharmaceutical
Products and Nanoparticles)</h4>
<p>Other antifungal therapeutic
options include those based on biopharmacological products (e.g.,
monoclonal antibodies, cytokines, vaccines, or antifungal peptides)
or nanoparticles. Because monoclonal
antibodies are highly target-specific, their use as antifungal therapeutics
offers a significant advantage, making them a potentially safe option
with minimal side effects. Examples of effective monoclonal antibodies
include efungumab and 18B7. However, despite several other monoclonal
antibodies showing both <em>in vitro</em> and <em>in vivo</em> efficacy, no such products are currently under development for clinical
use, which may be due to the high cost of production technology.
</p>
<p>Cytokines (e.g., recombinant macrophage
colony-stimulating factor, interferon-γ) or other proteins may
be used in immunotherapeutic antifungal strategies. Cytokines stimulate
the host’s immune system, enhancing defense against fungal
infections. However, more extensive and complex clinical trials are
necessary to understand their mechanisms of action and ensure safe
application for treating fungal infections. Recombinant macrophage
colony-stimulating factor is a promising candidate that has long been
used for the clinical treatment of neutropenia.
</p>
<p>Vaccination is another encouraging option to prevent
fungal infections
and spread, particularly in regions where pathogenic fungi pose a
significant issue and hospital treatment is either prohibitively expensive
or unavailable (typically low-income countries). Because it is challenging
to enhance immune defense in immunosuppressed patients through vaccination,
vaccines are primarily envisioned as prophylactic agents for use in
immunocompetent populations. No commercially
available antifungal vaccines exist, but two are under development
and have shown promising results in clinical trials. The NDV-3A vaccine
comprises the N-terminal domain of a protein with agglutinin-like
sequences (Als3) combined with an aluminum hydroxide adjuvant. Als3
is an immunodominant cell wall protein of that functions as a virulence factor. NDV-3A has demonstrated effectiveness
in phase II clinical trials for treating infections caused by various <em>Candida</em> species. Its mechanism of action is based on reducing
pathogenic virulence, while enhancing the production and activation
of phagocyte effectors. The recombinant NXT-2 vaccine is based on
a modified Kex1 protein (serine-type carboxypeptidase) designed to
achieve protection against a broad antifungal spectrum by stimulating
the production of anti-NXT-2 antibodies, which bind to fungal cells
and promote phagocytosis. Additional advantages include inhibiting
biofilm formation and cost-effective production, and tests indicate
that it may be effective against , , , and infections.
It is currently undergoing phase I clinical trials.
</p>
<p>Antifungal peptides offer several advantages over
traditional antifungal
agents. They are naturally derived, making them potential biopharmacological
products. They act across a broad spectrum, enabling their effectiveness
against various fungal infections. Furthermore, their selective mode
of action targets fungi, while minimizing the risk of side effects.
Moreover, the risk of resistance development is minimal because they
typically have a rapid mode of action and are fungicidal, attacking
multiple fungal-specific targets using diverse mechanisms.<em>
−

</em> Generally, the mechanism of action is dependent on the peptide concentration.
At relatively high concentrations, antifungal peptides directly disrupt
the cell membrane, causing rapid cell death. They exert various effects
at lower concentrations, including directly or indirectly inhibiting
cell wall synthesis, binding to nucleic acids to cause degradation,
suppressing transcription, disrupting organelle function (e.g., mitochondria
and vacuoles), inducing reactive oxygen species accumulation, triggering
programmed cell death and autophagy, disturbing ion homeostasis, altering
fungal metabolism, activating signal transduction pathways, and interfering
with the cell cycle.<em>
,
</em> Despite their many advantages,
antifungal peptides also have several drawbacks that significantly
affect their practical applicability, including high instability within
the host organism (mainly due to enzymatic degradation), host cell
lysis when applied at high concentrations, unresolved drug delivery
and targeting, low yield, and high production cost. Due to their unfavorable
pharmacokinetic and pharmacodynamic properties, the medical application
of antifungal peptides is currently envisioned in the form of topical
agents for the treatment of various types of candidiasis, either as
a stand-alone therapy or in combination with traditional antifungal
agents.<em>
−

</em> Several such peptides have reached various stages
of clinical trials, but only a few have been commercialized as therapeutic
agents. For instance, the peptide P113 demonstrated effectiveness
against oral, vaginal, and ocular candidiasis, and NP213 showed promise
for treating onychomycosis, although it failed placebo-controlled
tests. Regarding systemic applications
for treating invasive mycoses, hLF(1–11) and CZEN-002 are promising
candidates. hLF(1–11) directly destroys pathogens, while CZEN-002
enhances the host’s immune defense. Despite promising clinical
trials, neither has been commercialized to date. The previously mentioned and development-stage agents,
such as nikkomycin Z, aureobasidin A, and VL-2397, are broadly effective
in treating fungal infections of diverse origins and types. Additional promising candidates for treating <em>Candida</em> infections include cathelicidins (e.g., LL-5, LL-37,
omiganan, and iseganan), histatins (e.g., histatin 5), mucins (e.g.,
PAC113), and other peptides (e.g., lactoferrin, WLBU2, and XF-73),
many of which have already reached various stages of clinical trials.<em>
,
</em> Two lactoferrin-derived peptides (i.e., Lf(1–11) and bLfcin)
are notable as potential adjuvants because they exhibit synergistic
effects against <em>Candida</em> species when combined with
azoles or amphotericin B70. Moreover, many antifungal peptides have
shown effectiveness in preventing biofilm formation and destroying
already existing biofilms. This is mainly achieved by inhibiting surface
adhesion and negatively regulating genes involved in the complex processes
of biofilm formation, such as those regulating the transition from
planktonic cells to pseudohyphae to hyphae. Such peptides include
certain defensins, cathelicidins, histatins, and <em>de novo</em>-designed peptides.
</p>
<p>The application
of nanotechnology in treating fungal infections
has emerged in recent years. This involves binding antifungal agents
to nanoparticles or packaging in nanocapsules to improve their pharmacokinetic
and pharmacodynamic properties. Examples include lipid nanoparticles,
such as amphotericin B in liposomal bilayers (AmBisome), or nanopolymers.
Metallic nanoparticles (e.g., silver, gold, and magnetite) have also
demonstrated effective antifungal activity, although their clinical
application remains unelucidated.
</p></section><section id="sec2.2.6"><h4 class="pmc_sec_title">2.2.6. Artificial Intelligence (AI) in Antifungal
Drug Development</h4>
<p>These days, artificial intelligence (AI)
is revolutionizing antifungal drug development and therapies, reducing
time and costs while enhancing predictive models for efficacy and
safety. Additionally, AI facilitates biomarker identification and
personalized treatment strategies, leading to more effective and tailored
antifungal therapies. Machine learning models surpass traditional
screening methods by processing genomic, proteomic, and metabolomic
data to identify promising drug candidates. AI-driven predictive modeling
assesses drug interactions, toxicity profiles, and pharmacokinetic
properties, optimizing development processes.<em>
,
</em> AI also aids in identifying resistance patterns in fungal pathogens,
enabling the design of targeted therapies for multidrug-resistant
strains, accelerating the discovery of novel treatments. AI plays a key role in drug repurposing for
antifungal applications by analyzing molecular structures and predicting
efficacy. Leveraging clinical data sets and natural language processing,
AI discovers new therapeutic indications for existing antifungal agents.<em>
,
</em> Advanced techniques, such as reinforcement learning and generative
adversarial networks, further refine drug effectiveness and enhance
therapeutic potential, improving accessibility, efficacy, and affordability.
AI-driven screening methods identify agents with improved efficacy
and lower toxicity while optimizing formulations and refining safety
models. Machine learning algorithms contribute to streamlining clinical
trials, improving therapeutic strategies, and increasing treatment
success rates. Personalized antifungal treatment is enhanced by AI
through analyzing individual patient data, optimizing therapeutic
efficacy, and minimizing adverse effects. By integrating genomic information,
microbiome composition, and treatment history, AI-driven models assist
clinicians in selecting the most effective therapies and improving
treatment precision, patient adherence, and clinical outcomes. AI
further enables real-time monitoring of patient responses, allowing
timely therapeutic adjustments.<em>
,
</em> Despite its transformative
potential, AI integration in antifungal drug development faces challenges,
including limited high-quality data sets, regulatory hurdles, and
ethical concerns regarding data privacy and accessibility. Addressing
these challenges through interdisciplinary collaboration, standardized
data collection, and clear validation guidelines will improve the
reliability of AI and its impact on antifungal therapy.
</p></section></section></section><section id="sec3"><h2 class="pmc_sec_title">3. Management of Plant Pathogenic Fungi</h2>
<p>The most widely used chemical fungicides worldwide can be classified
into 15 major groups, according to their chemical properties and modes
of action (<a href="#tbl6" class="usa-link">Table 
</a>). <a href="#fig5" class="usa-link">Figure 
</a> presents the chemical
structures of representative fungicides from the 15 major groups.
These fungicides are categorized as either contact or systemic. Contact
fungicides provide surface protection against pathogenic fungi and
do not penetrate plant tissues. In contrast, systemic fungicides enter
the plant and are distributed evenly through the vascular system,
offering protection against pathogens capable of penetrating the plant.</p>
<section class="tw xbox font-sm" id="tbl6"><h3 class="obj_head">6. Most Widely Applied Chemical Fungicide
Groups Globally<sup></sup>
.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">group</th>
<th align="center" colspan="1" rowspan="1">chemical
family</th>
<th align="center" colspan="1" rowspan="1">example fungicide</th>
<th align="center" colspan="1" rowspan="1">target</th>
<th align="center" colspan="1" rowspan="1">mode of action</th>
<th align="center" colspan="1" rowspan="1">effect</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" align="left" colspan="1">aniline pyrimidines</td>
<td rowspan="2" align="left" colspan="1">aniline pyrimidine</td>
<td align="left" colspan="1" rowspan="1">cyprodinil</td>
<td rowspan="2" align="left" colspan="1">cystathionine-β-synthase,
cystathionine-β-lyase</td>
<td rowspan="2" align="left" colspan="1">inhibits secretion
of hydrolytic enzymes needed for infection by interfering with methionine
biosynthesis</td>
<td rowspan="2" align="left" colspan="1">systemic</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">pyrimethanil</td></tr>
<tr>
<td rowspan="3" align="left" colspan="1">demethylation
inhibitors</td>
<td rowspan="3" align="left" colspan="1">triazole</td>
<td align="left" colspan="1" rowspan="1">epoxiconazole</td>
<td rowspan="3" align="left" colspan="1">lanosterol-14α-demethylase</td>
<td rowspan="3" align="left" colspan="1">inhibits ergosterol
biosynthesis through lanosterol-14α-demethylase inhibition</td>
<td rowspan="3" align="left" colspan="1">systemic</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">prothioconazole</td></tr>
<tr><td align="left" colspan="1" rowspan="1">tebuconazole</td></tr>
<tr>
<td rowspan="2" align="left" colspan="1">dicarboximides</td>
<td rowspan="2" align="left" colspan="1">dicarboximide</td>
<td align="left" colspan="1" rowspan="1">iprodione</td>
<td rowspan="2" align="left" colspan="1">MAP/histidine
kinase</td>
<td rowspan="2" align="left" colspan="1">blocks signal
transduction</td>
<td rowspan="2" align="left" colspan="1">systemic</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">vinclozolin</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">dithiocarbamate (derivatives)</td>
<td align="left" colspan="1" rowspan="1">dithiocarbamate (derivatives)</td>
<td align="left" colspan="1" rowspan="1">mancozeb</td>
<td align="left" colspan="1" rowspan="1">multiple targets</td>
<td align="left" colspan="1" rowspan="1">acts on multiple targets</td>
<td align="left" colspan="1" rowspan="1">contact</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">phenylamides</td>
<td align="left" colspan="1" rowspan="1">acylalanine</td>
<td align="left" colspan="1" rowspan="1">metalaxyl (mefenoxam)</td>
<td rowspan="2" align="left" colspan="1">RNA polymerase
I</td>
<td rowspan="2" align="left" colspan="1">inhibits
RNA
synthesis</td>
<td rowspan="2" align="left" colspan="1">systemic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">methylalanine</td>
<td align="left" colspan="1" rowspan="1">benalaxyl</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">phenylpyrroles</td>
<td align="left" colspan="1" rowspan="1">phenylpyrrole</td>
<td align="left" colspan="1" rowspan="1">fludioxonil</td>
<td align="left" colspan="1" rowspan="1">MAP/histidine kinase</td>
<td align="left" colspan="1" rowspan="1">blocks signal transduction</td>
<td align="left" colspan="1" rowspan="1">contact</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">phosphonates</td>
<td align="left" colspan="1" rowspan="1">ethylphosphonate</td>
<td align="left" colspan="1" rowspan="1">fosetyl</td>
<td align="left" colspan="1" rowspan="1">phosphonate</td>
<td align="left" colspan="1" rowspan="1">inhibits mycelium growth
and sporulation</td>
<td align="left" colspan="1" rowspan="1">systemic</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">inorganic
molecules</td>
<td align="left" colspan="1" rowspan="1">inorganic
sulfur</td>
<td align="left" colspan="1" rowspan="1">sulfur</td>
<td align="left" colspan="1" rowspan="1">proteins</td>
<td align="left" colspan="1" rowspan="1">inhibits germination, respiration,
and metabolism</td>
<td rowspan="3" align="left" colspan="1">contact</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">inorganic copper</td>
<td align="left" colspan="1" rowspan="1">copper hydroxide</td>
<td rowspan="2" align="left" colspan="1">amino acids,
proteins</td>
<td rowspan="2" align="left" colspan="1">enzyme inhibition</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">copper oxychloride</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">carbamates</td>
<td align="left" colspan="1" rowspan="1">carbamate</td>
<td align="left" colspan="1" rowspan="1">propamocarb</td>
<td align="left" colspan="1" rowspan="1">acetylcholinesterase</td>
<td align="left" colspan="1" rowspan="1">inhibits cell membrane biosynthesis
by disrupting lipid biosynthesis</td>
<td align="left" colspan="1" rowspan="1">Systemic</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">carboxylic
acid amides</td>
<td rowspan="2" align="left" colspan="1">carboxylic
acid amide</td>
<td align="left" colspan="1" rowspan="1">dimethomorph</td>
<td rowspan="2" align="left" colspan="1">cellulose synthase</td>
<td rowspan="2" align="left" colspan="1">inhibits cell
wall biosynthesis through cellulose synthase inhibition</td>
<td rowspan="2" align="left" colspan="1">systemic</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">mandipropamid</td></tr>
<tr>
<td rowspan="5" align="left" colspan="1">quinone
inhibitors</td>
<td align="left" colspan="1" rowspan="1">enoyl
ester</td>
<td align="left" colspan="1" rowspan="1">picoxystrobin</td>
<td align="left" colspan="1" rowspan="1">cytochrome <em>b</em>
</td>
<td rowspan="5" align="left" colspan="1">inhibits
cellular
respiration</td>
<td rowspan="5" align="left" colspan="1">systemic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">carboxamide</td>
<td align="left" colspan="1" rowspan="1">fenpicoxamid</td>
<td align="left" colspan="1" rowspan="1">cytochrome bc1 complex III</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">methoxy-acrylate</td>
<td align="left" colspan="1" rowspan="1">azoxystrobin</td>
<td rowspan="3" align="left" colspan="1">cytochrome <em>b</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">methoxy-carbamate</td>
<td align="left" colspan="1" rowspan="1">pyraclostrobin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">sulfonamide</td>
<td align="left" colspan="1" rowspan="1">amisulbrom</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">methylbenzimidazole
carbamates</td>
<td rowspan="3" align="left" colspan="1">thiophanate</td>
<td align="left" colspan="1" rowspan="1">benomyl</td>
<td rowspan="3" align="left" colspan="1">β-tubulin</td>
<td rowspan="3" align="left" colspan="1">inhibits mitosis
and cell division</td>
<td rowspan="3" align="left" colspan="1">systemic</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">carbendazim</td></tr>
<tr><td align="left" colspan="1" rowspan="1">thiophanate-methyl</td></tr>
<tr>
<td rowspan="2" align="left" colspan="1">morpholines/amines</td>
<td align="left" colspan="1" rowspan="1">pyrimidinamine</td>
<td align="left" colspan="1" rowspan="1">fenpropimorph</td>
<td align="left" colspan="1" rowspan="1">Δ8−Δ7- sterol isomerase, Δ14-sterol reductase</td>
<td rowspan="2" align="left" colspan="1">inhibits ergosterol
biosynthesis through Δ8−Δ7- sterol isomerase/Δ14-sterol reductase inhibition</td>
<td rowspan="2" align="left" colspan="1">systemic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">spiroketalamine</td>
<td align="left" colspan="1" rowspan="1">spiroxamine</td>
<td align="left" colspan="1" rowspan="1">Δ14 sterol reductase</td>
</tr>
<tr>
<td rowspan="4" align="left" colspan="1">succinate
dehydrogenase
inhibitors</td>
<td align="left" colspan="1" rowspan="1">aromatic
amide</td>
<td align="left" colspan="1" rowspan="1">fluxapyroxad</td>
<td rowspan="4" align="left" colspan="1">succinate dehydrogenase/complex
II</td>
<td rowspan="4" align="left" colspan="1">inhibits
succinate
dehydrogenase, blocking mitochondrial ATP production</td>
<td rowspan="4" align="left" colspan="1">systemic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">pyrazole carboxamide</td>
<td align="left" colspan="1" rowspan="1">bixafen</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">pyridyl ethylbenzamide</td>
<td align="left" colspan="1" rowspan="1">fluopyram</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">pyridine carboxamide</td>
<td align="left" colspan="1" rowspan="1">boscalid</td>
</tr>
<tr>
<td rowspan="3" align="left" colspan="1">multitarget
agents</td>
<td align="left" colspan="1" rowspan="1">dinitrile</td>
<td align="left" colspan="1" rowspan="1">chlorothalonil</td>
<td rowspan="3" align="left" colspan="1">multiple</td>
<td rowspan="3" align="left" colspan="1">acts on multiple
targets</td>
<td rowspan="3" align="left" colspan="1">contact</td>
</tr>
<tr>
<td rowspan="2" align="left" colspan="1">phthalimide</td>
<td align="left" colspan="1" rowspan="1">folpet</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">captan</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t6fn1">
<sup>a</sup><p class="display-inline">ATP: adenosine triphosphate, MAP:
mitogen-activated protein. Compiled based on tables edited by Gikas
et al. and Corkley et al.
</p>
</div></div></section><figure class="fig xbox font-sm" id="fig5"><h3 class="obj_head">5.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371507_bg5c00103_0005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/e078a048abf4/bg5c00103_0005.jpg" loading="lazy" id="gr5" height="849" width="777" alt="5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chemical
structures of representative fungicides from the 15 major
groups of chemical fungicides.</p></figcaption></figure><p>
<a href="#tbl6" class="usa-link">Table 
</a> shows only
a few selected examples because the number of chemical fungicides
continuously increases with newer ones being brought to market, mainly
in the United States.<em>
,
</em> The opposite trend is observed
in the EU, where an increasing number of fungicides are being (temporarily
or permanently) withdrawn from the market and banned under the Toward
Zero Pollution for Air, Water and Soil action plan and other regulations.<em>
,,
</em> Some withdrawn fungicides may
be temporarily reauthorized by the EU in emergencies. The list of
currently authorized fungicides is continuously monitored and can
be found on the relevant EU web portals.</p>
<p>Fungi cause significant
damage in the field and under storage conditions,
contaminating harvested crops with mycotoxins, which are harmful secondary
metabolites that pose serious health risks.<em>
,
</em>
</p>
<section id="sec3.1"><h3 class="pmc_sec_title">3.1. Challenges in Managing Plant Pathogenic Fungi</h3>
<p>The protection of plants against fungal pathogens continues to
face new challenges in pre- and postharvest conditions.<em>
,−

</em> Among the most significant challenges are (1) the
emergence of new fungal species in agricultural areas where they were
previously unknown (due to climate change), (2) the continuous spread
of fungicidal resistance, and (3) the harmful effects of chemical
fungicides on the environment and human health.</p>
<section id="sec3.1.1"><h4 class="pmc_sec_title">3.1.1. Emergence of New Plant Pathogenic Fungal
Species</h4>
<p>It has been established that due to climate change,
the incidence and impact of fungal infections on plants and crops
are continuously increasing in pre- and postharvest conditions. Additionally, a further significant increase
is expected in the near future, resulting
from direct and indirect causes. Direct causes include the emergence
of plant pathogenic fungal species, such as , , species complex, , , , <em>Pythium</em> spp., and f. sp. <em>tritici</em>, in agricultural areas, where they
were previously unknown. Additional direct causes include higher average
temperatures, which can, for instance, shorten pathogen generation
times; elevated CO<sub>2</sub> levels, which either increase or decrease
infection severity; and increased humidity or prolonged droughts,
which enhance fungal pathogen virulence. These factors also influence the nature and extent of mycotoxin
contamination under storage conditions such as the appearance of and species complex. Indirect causes include
reduced levels of plant resistance and changes in the rhizobiome,
which may reduce the number of beneficial competitor microorganisms
in the soil surrounding the roots, thereby diminishing the plant’s
defense capabilities against pathogenic fungi.
</p></section><section id="sec3.1.2"><h4 class="pmc_sec_title">3.1.2. Resistance</h4>
<p>Over the past 2 decades,
the widespread improper use of chemical fungicides (i.e., incorrect
fungicide selection, inappropriate timing and concentration, and neglecting
rainy weather periods) has caused the emergence of an increasing number
of resistant plant pathogenic fungal strains. This phenomenon is primarily attributed to the genomic plasticity
of fungi and their broad genetic toolkit, equipping them with excellent
adaptive and resistance capabilities against fungicides.<em>
,
</em>
<a href="#fig6" class="usa-link">Figure 
</a> comprehensively
summarizes the resistance mechanisms developed against the chemical
fungicides. The underlying resistance mechanisms most commonly involve
one or more of the following mechanisms: (1) target gene mutation,
(2) target overproduction, (3) reduction of fungicide concentration
within the cell through efflux processes, and (4) detoxification via
metabolic breakdown of the fungicide.</p>
<figure class="fig xbox font-sm" id="fig6"><h5 class="obj_head">6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371507_bg5c00103_0006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c76/12371507/c731342eb468/bg5c00103_0006.jpg" loading="lazy" id="gr6" height="1057" width="750" alt="6"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mechanisms of action of chemical fungicide
classes and the associated
principal forms of acquired resistance. (a) Aniline pyrimidine resistance:
(1) target gene (methionine biosynthesis enzyme genes) mutations,
(2) efflux pump hyperactivity, and (3) adenosine triphosphate-binding
cassette transporter overexpression. Mechanism of action (MA): inhibition
of methionine biosynthesis and hydrolytic enzyme secretion. (b) Demethylation
inhibitor resistance: (1) target gene (lanosterol 14α-demethylase)
point mutations, (2) target overproduction, (3) efflux pump overproduction
or hyperactivity, (4) hypermutation in the target and housekeeping
genes, (5) heteroresistance and aneuploidy, and (6) metabolic changes
and degradation. MA: lanosterol 14α-demethylase inhibition.
(c) Dicarboximide and phenylpyrrole inhibitor resistance: (1) target
gene (mitogen-activated protein kinase/histidine kinase) mutations,
(2) efflux pump hyperactivity, and (3) adenosine triphosphate-binding
cassette transporter overexpression. MA: signal transduction blocking.
(d) Quinone inhibitor resistance: (1) target gene (cytochrome <em>b</em>/<em>c</em>) mutations, (2) efflux pump hyperactivity,
and (3) metabolic changes and degradation. MA: cellular respiration
inhibition. (e) Methylbenzimidazole carbamate resistance: (1) target
gene (β-tubulin) mutations and (2) target overproduction. MA:
mitosis and cell division inhibition. (f) Morpholine/amine resistance:
(1) unknown. MA: Δ8−Δ7-sterol isomerase/Δ14-sterol
reductase inhibition. (g) Succinate dehydrogenase inhibitor resistance:
(1) target gene (succinate dehydrogenase/complex II) mutations and
(2) efflux pump hyperactivity. MA: succinate dehydrogenase inhibition
and mitochondrial adenosine triphosphate production blocking. CBL:
cystathionine-β-lyase, CBS: cystathionine-β-synthase,
CYP51A/ERG11: lanosterol 14α-demethylase, CYT B/C: cytochrome <em>b</em>/<em>c</em>, ERG2: Δ8−Δ7-sterol
isomerase, ERG24: Δ14-sterol reductase, HK: histidine kinase,
MAP: mitogen-activated protein kinase, <em>MSH2</em>: azole
resistance gene, SDH: succinate dehydrogenase, TUB2: β-tubulin.
Asterisks indicate mutations. The figure is compiled using information
presented in Hawkins and Fraaije, and
Brauer et al. and updated with the original
literature findings.</p></figcaption></figure><p>The most common resistance mechanism against aniline
pyrimidines
is the overproduction of energy-dependent efflux pumps (adenosine
triphosphate-binding cassette transporters), thereby reducing the
intracellular concentration of the fungicide to ineffective levels.
The increased activity of alternative efflux pumps and mutations in
genes associated with methionine biosynthesis also contribute to resistance
(<a href="#fig6" class="usa-link">Figure 
</a>a). At least
one of these resistance mechanisms has been identified in , <em>Oculimacula</em> spp., and .
</p>
<p>Resistance to demethylation inhibitors is mainly due to point
mutations
in the gene encoding the target enzyme (i.e., mutations in lanosterol
14α-demethylase, resulting in the inability or reduced ability
of azoles to inhibit enzymatic activity) or enzyme overproduction
(i.e., increased enzyme production compensates for the inhibitory
effect of the intracellular azole concentration). Other mechanisms
contributing to resistance against demethylation inhibitors include
hypermutations in both the target and housekeeping genes, heteroresistance,
aneuploidy, metabolic adaptations, and fungicide degradation (<a href="#fig6" class="usa-link">Figure 
</a>b). One or more of
these resistance mechanisms have been observed in , , , , and , , and .
</p>
<p>Resistance to dicarboximide and phenylpyrrole fungicides was
established
in and is mainly attributed
to mutations in the gene encoding histidine kinase, thereby preventing
the fungicide from binding to the enzyme and inhibiting its function
(<a href="#fig6" class="usa-link">Figure 
</a>c).
</p>
<p>Besides efflux pump hyperactivity, resistance
to quinone inhibitors
is caused by point mutations in the mitochondrial cytochrome <em>b</em> and <em>c</em> genes, preventing the fungicide
from binding to its target site and inhibiting cellular respiration.
These resistance mechanisms have been well characterized in , , , , , <em>-repentis</em>, and (<a href="#fig6" class="usa-link">Figure 
</a>d).
</p>
<p>To date, approximately 115 fungal species have developed resistance
to methylbenzimidazole carbamates, and the mechanism has been well
characterized in and . Resistance is mainly due to point
mutations in the β-tubulin gene, reducing or preventing the
fungicide from binding to and inhibiting β-tubulin function
(<a href="#fig6" class="usa-link">Figure 
</a>e).
</p>
<p>Resistance to morpholine and amine fungicides
has been reported
in <em>Erysiphe</em> spp., <em>Microsphaera</em> spp., <em>Phyllactinia</em> spp., <em>Podosphaera</em> spp., <em>Sphaerotheca</em> spp., and <em>Uncinula</em> spp. However,
the underlying molecular mechanisms remain unknown (<a href="#fig6" class="usa-link">Figure 
</a>f).
</p>
<p>The extensive and widespread use of succinate dehydrogenase
inhibitors
rapidly led to the emergence of resistant fungal strains due to an
amino acid substitution in histidine at position 257 of the enzyme,
preventing fungicide binding. Efflux pump hyperactivity was also implicated
in the resistance mechanism. Resistance to succinate dehydrogenase
inhibitors has been reported in , , , , and (<a href="#fig6" class="usa-link">Figure 
</a>g).
</p>
<p>Any discussion of fungicide resistance must address
the widespread
and intensive use of azole-based fungicides in agricultural areas.
This significantly promotes the development of human pathogenic strains resistant to clinically used
triazoles.
</p></section><section id="sec3.1.3"><h4 class="pmc_sec_title">3.1.3. Harmful Impact on the Environment and Human
Health</h4>
<p>Introducing chemical fungicides into the environment
promotes the development of resistant fungal strains and directly
or indirectly harms the environment and human health. Because of their
physicochemical properties, many fungicides accumulate in soil and
surface or groundwater, affecting water quality and exerting significant
harmful effects on the organisms in these ecosystems through direct
toxicity or indirect ecotoxicological processes.<em>
,
</em>
</p>
<p>The direct toxic effects of chemical fungicides largely depend
on their fungal-specific modes of action, and fungicides targeting
nonfungal-specific sites may also harm other organisms. Although inorganic
fungicides (e.g., copper- and sulfur-based) pose the lowest toxicological
risk, they accumulate in aquatic organisms (e.g., algae, fish, and
crustaceans), impact food quality upon consumption, and alter soil
microbiome composition. Among chemical
fungicides, demethylation inhibitors mainly harm non-plant pathogenic
fungi. Although their toxicity to aquatic plants, invertebrates, and
vertebrates is low, they disrupt sex steroid production in fish and
amphibians, causing imbalanced gender ratios. Methylbenzimidazole
carbamates exhibit low toxicity to aquatic microorganisms, plants,
and vertebrates; moderate toxicity to non-plant pathogenic fungi;
and low to moderate toxicity to algae, bacteria, and crustaceans.
Quinone inhibitors harm aquatic invertebrates and amphibians to a
low or moderate extent. Carbamates are low or moderately toxic to
algae, bacteria, and crustaceans. A
direct correlation exists between intensive agricultural use of fungicides
and declining populations of honeybees and other critical pollinators.
Some fungicides disrupt the microbiome of the digestive system of
bees, resulting in metabolic imbalances and mortality.
</p>
<p>The indirect harmful effects of chemical
fungicides are primarily
manifested through ecotoxicological processes. Inorganic fungicides
(e.g., copper- and sulfur-based) influence the quantity and quality
of nutrients available to plants by altering the soil structure and
microbiome composition, reducing the resistance of plants to pathogens. High levels of fungicide accumulation promote
biofilm formation by pathogenic microorganisms, enhancing their resistance
and virulence. Additionally, the significant toxic effects of fungicides
on certain organisms disrupt predator–prey and host–pathogen
balances. Mass bee mortality caused
by the intensive application of fungicides causes ecological disasters
and negatively impacts agricultural food production.
</p>
<p>Regarding human health, the intensive application
of chemical fungicides
is likely linked to various chronic illnesses (e.g., cancer and cardiovascular,
respiratory, and neurological diseases). A recent extensive survey
of five European countries detected the presence of at least two pesticides
(including fungicides) in 84% of participants. The effects of fungicides
on human health are not yet fully elucidated and warrant further investigation.
</p>
<p>The challenges discussed above may be
mitigated by the previously
mentioned EU action plan (Toward Zero Pollution for Air, Water and
Soil), which advocates for developing
novel antifungal agricultural strategies with a low environmental
impact.</p></section></section><section id="sec3.2"><h3 class="pmc_sec_title">3.2. New Trends in Plant Pathogenic Fungi Management</h3>
<p>The expectations for a new type of fungicide are similar to those
discussed for antifungal drugs used in human medicine, with the most
critical criteria being a broad antifungal spectrum, minimal risk
of resistance development, and a fungus-specific mode of action. The
first two ensure long-term and effective application, while the latter
ensures safe use with minimal environmental impact. Such approaches may include developing chemical fungicides
with novel modes of action, using biocontrol agents and naturally
occurring biomolecules, or creating new and more effective formulations
and targeted delivery methods.</p>
<section id="sec3.2.1"><h4 class="pmc_sec_title">3.2.1. Chemical Fungicides with Novel Modes of
Action</h4>
<p>The currently available or recently under development
fungicidal arsenal eliminates plant pathogenic fungi through approximately
52 different mechanisms targeting major physiological processes, such
as nucleic acid metabolism, cytoskeleton and motor proteins, cell
respiration, amino acid and protein synthesis, signal transduction,
lipid biosynthesis, transport processes, membrane integrity, melanin
synthesis, cell membrane components, and cell wall biosynthesis. Some of the components involved in these processes
may be potential targets for developing new fungus-specific chemical
fungicidal molecules with novel modes of action and can be identified
from molecule libraries using laboratory-based or <em>in silico</em> high-throughput screening techniques. Such molecules can be specifically
modified for improved fungal specificity. Chemical fungicides with novel modes of action identified and modified
using these techniques include dihydroorotate dehydrogenase inhibitors,
oxysterol-binding protein inhibitors, melanin biosynthesis inhibitors,
and Gwt1 protein inhibitors.
</p>
<p>Dihydroorotate
dehydrogenase inhibitors (e.g., ipflufenoquin and quinofumelin) bind
to the enzyme to block pyrimidine-based nucleotide biosynthesis. They
have demonstrated their effectiveness against and fungi, causing gray mold disease and powdery mildew, and there
are no reports of cross-resistance. Olorofim, a similar antifungal
molecule developed for human therapeutic use (<a href="#tbl5" class="usa-link">Table 
</a>), has demonstrated efficacy against , , and .
</p>
<p>Oxysterol-binding protein inhibitors
(e.g., oxathiapiprolin and
fluoxapiprolin) block lipid transfer. They act on a narrow spectrum
and are effective against members of the class Oomycetes. Laboratory
tests suggest a moderate to high risk of resistance development and
potential cross-resistance.
</p>
<p>Melanin
biosynthesis inhibitors, such as tricyclazole, suppress
melanin biosynthesis, which is essential for infection via the appressorium
by inhibiting hydroxy-naphthalene reductase or trihydroxy-dihydronaphthalene
dehydratase. However, there is a high risk of resistance and cross-resistance.
Tolprocarb is another melanin biosynthesis inhibitor, but it inhibits
polyketide synthase. Tolprocarb resistance has been observed but not
cross-resistance. These compounds are primarily effective against , which causes rice blast.
</p>
<p>Gwt1 protein inhibitors, such as aminopyrifen,
were developed as
human therapeutics that prevent the incorporation of mannoprotein
into the cell wall (<a href="#tbl5" class="usa-link">Table 
</a>). They are effective against both ascomycetous and basidiomycetous
phytopathogenic fungi including , f. sp. <em>tritici</em>, , and . However, resistance and cross-resistance
may develop.
</p>
<p>Due to the aforementioned
high-throughput screening techniques,
fungicidal candidate molecules with novel, previously unknown mechanisms
of action have been identified, such as tebufloquin against and ; picarbutrazox against <em>Pythium</em> spp., <em>Fusarium</em> spp., and <em>Rhizopus</em> spp.; and dipymetitrone against <em>Phytophthora</em> spp., <em>Botrytis</em> spp., and powdery
mildew.
</p></section><section id="sec3.2.2"><h4 class="pmc_sec_title">3.2.2. Biocontrol Agents and Biomolecules</h4>
<p>The application of biocontrol agents or biomolecules derived from
various organisms as pesticides has a lower environmental impact and
ecological risk compared with chemical fungicides.
</p>
<p>Several fungicidal biocontrol agents have been identified
in recent years. These agents are typically antagonistic microorganisms
that effectively suppress or eliminate pathogens from their environment
via competition, mycoparasitism, or antibiosis, without harming the
host or the rhizobiome. They may also
release molecules into the environment that enhance plant defense
mechanisms. For soilborne plant pathogenic fungi (<em>Fusarium</em> spp., <em>Pythium</em> spp., <em>Phytophthora</em> spp., , <em>Sclerotinia</em> spp., , and ), <em>Trichoderma</em> species (such as , , , and ) are particularly
effective, along with various bacterial species (<em>Bacillus</em> spp., <em>Burkholderia</em> spp., <em>Pseudomonas</em> spp., and <em>Streptomyces</em> spp.). Topically applied
biocontrol agents are effective against airborne fungal pathogens,
such as <em>Chaetomium</em> spp. against and , against <em>Monilinia</em> spp., and against . Additionally, <em>Bacillus</em> spp. effectively inhibit the growth of , whereas inhibits the growth of , , , , , , and . Under storage conditions, proved to be effective against and , whereas mitigated
the damage caused by and . Currently approved biocontrol
products include those based on <em>Bacillus</em> spp., , <em>Streptomyces</em> spp., , , , , , , , <em>Trichoderma</em> spp., and <em>-atrum</em>.
</p>
<p>Biomolecules
derived from plants or other organisms can also effectively
protect plants against fungi by destroying fungal pathogens and stimulating
the defense system, growth, and biotic stress resistance of plant
hosts. Examples include plant probiotics, phytochemicals, and short double-stranded RNA molecules and antifungal peptides.
</p>
<p>Plant probiotics exert a multifaceted
effect, promoting plant growth
(e.g., stimulating auxin, ethylene, gibberellin, and cytokinin production),
making nutrients accessible (e.g., bacterial siderophores), and increasing
resistance to stress factors, including biotic factors (e.g., antifungal
compounds and pathogen inhibitors). Phytochemicals
include raw plant extracts or secondary metabolites derived from plants.
Many plant extracts have effectively mitigated fungal infections and
damaged fungal pathogens. Due to their fungal selectivity, they pose
a minimal risk of resistance development and environmental harm. However,
challenges such as large-scale, cost-effective production, and field-effective
formulations must be overcome. Currently, seven phytochemical products
from plants (e.g., , , , and ) are commercially available, mainly effective
against <em>Botrytis</em>, <em>Fusarium</em>, and
powdery mildew infections.
</p>
<p>Plant
protection strategies based on short double-stranded RNA
molecules and peptides are available at various stages of technological
advancement. Double-stranded RNA molecules primarily exert their antifungal
effects through RNA interference, targeting genes essential for fungal
cellular structure or metabolism. Numerous
antifungal peptides, originating from various organisms or synthesized <em>de novo</em>, have effectively inhibited the growth of field
crop pathogens and storage pest fungi.<em>
,,
</em> Their advantageous properties for specific agricultural
applications include fungicidal activity at relatively low concentrations,
low risk of resistance development, synergistic interactions with
some chemical fungicides and plant defense systems against pathogens,
and potential plant growth stimulation by influencing symbiosis. However,
their disadvantage is the relatively high production cost. As previously
discussed, antifungal peptides and proteins inhibit the growth of
plant pathogenic fungi or kill them through distinct mechanisms (e.g.,
cell membrane disruption, inducing apoptosis).<em>
,
</em> Two approaches can be used to integrate antifungal peptides/proteins
into plant and crop protection: (1) development of cisgenic or transgenic
plants that express large amounts of self-derived or foreign antifungal
peptides/proteins, thereby enhancing their resistance to fungal pathogens,
and (2) applying antifungal peptides/proteins as biofungicides in
spray formulations. The first approach faces significant challenges
due to current regulations on genetically modified plants and consumer aversion toward foods derived
from genetically modified organisms. Thaumatin­(-like) proteins, thionins, defensins, hevein-like proteins,
knottin-like proteins, lipid transfer proteins, and snakin are suitable
candidates for creating antifungal peptide/protein-overproducing cisgenic
and transgenic plants. A practical example is an alfalfa antifungal
peptide-overproducing potato plant, which showed increased resistance
against and infections under field conditions. High
production costs, poor solubility, instability under environmental
conditions, and unresolved formulation and delivery technology hamper
the application of surface spray formulations of antifungal peptides/proteins
in fields.<em>
−

</em> Thus, only a few antifungal peptide- and
protein-based sprays have advanced beyond laboratory or greenhouse
trials. For example, under field conditions, NmDef02 from showed efficacy against ; trichogin from <em>Trichoderma</em> against ; synthetic
body protection compound peptides against , , and , , and ; and
ϵ-PL against . Some antifungal peptides/proteins of various
origins inhibit the proliferation of mycotoxigenic fungi (primarily <em>Aspergillus</em> spp., <em>Fusarium</em> spp., and <em>Penicillium</em> spp.) or reduce their mycotoxin production when
sprayed onto crops in storage conditions by inducing oxidative stress
and inhibiting specific enzymatic components of biosynthetic pathways.
</p></section><section id="sec3.2.3"><h4 class="pmc_sec_title">3.2.3. Formulation, Delivery, and Nanotechnology</h4>
<p>Issues such as safe and effective application and resistance development
arising with currently used and newly introduced chemical fungicides
may be overcome by using novel formulations and delivery techniques.
A new formulation must meet the following requirements: environmentally
friendly, resistant to extreme environmental conditions (e.g., UV
radiation, pH, temperature, evaporation, oxidation, etc.), favorable
physicochemical properties for targeted delivery, controllable and
precise application, and efficacy at low concentrations. Currently,
nanotechnology, which involves encapsulating existing chemical fungicides
or biomolecules (e.g., dsRNA, peptides, and plant metabolites) in
nanoparticles or binding them to nanoparticles,<em>
,
</em> or the utilization of specific nanoparticles as pesticides, provides
an excellent solution to these challenges.
</p>
<p>Experiments have shown that nanoparticle use reduces the environmental
impact and risk of resistance development, makes fungicides more resistant
to extreme environmental conditions, enables faster and more efficient
delivery, and is effective at lower doses than previously used. However,
the disadvantages of nanofungicides, such as complex production technologies,
high costs, and unclear effects on human health, hinder their application.<em>
,
</em> Nanomaterials used as fungicide carriers and packaging include carbon-based
materials (e.g., graphene and graphene oxide), synthetic anionic substances
(e.g., layered double hydroxides), silica nanoparticles, various polymers,
and metal nanoparticles. Iron­(II) oxide,
copper oxide, and titanium dioxide may be considered as stand-alone
nanofungicides. Many nanofungicides are
under development, but to date, none have been approved for agricultural
use in the EU due to the unclear long-term effects on animal and human
health.
</p></section></section></section><section id="sec4"><h2 class="pmc_sec_title">4. Conclusions and Outlook</h2>
<p>Despite the
efforts of decision-making bodies and the promising
solutions discussed, fungal infections continue to show a concerning
and rising trend. Although accelerating the implementation of the
action plans outlined in the WHO fungal priority pathogens list may
provide an effective solution for mitigating this issue, it requires significantly more financial support
and heightened public attention. The chronic underfunding of mycological
research must be addressed, with support
and substantial investment directed toward studies focused on improving
human welfare in the areas of healthcare, food supply, and food security.
Public awareness of global fungal-related challenges must also be
raised, urging communities to unite to address these problems. A potential
approach is the introduction of new initiatives involving civilian
participation in research efforts, such as sample collection for antifungal
drug resistance surveys,<em>
,
</em> monitoring the spread
of fungicide resistance, or even engaging
farmers in testing new agricultural antifungal strategies in the field. Increased public attention and societal collaboration
are expected to influence local political leaders and decision-making
bodies, driving antifungal problem-solving at the regional level,
eventually expanding to global-scale solutions.</p></section><section id="ACK-d14e3087-autogenerated" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The present work of L.G. was financed
by the Hungarian National
Research, Development and Innovation Office-NKFIH, FK 134343 and K
146131 projects. University of Szeged Open Access Fund, Grant ID:
7710. This article/publication is based upon work from COST Action
EURESTOP, CA21145, supported by COST (European Cooperation in Science
and Technology).</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Glossary</h2>
<h3>Abbreviations</h3>
<dl class="def-list" id="dl1">
<dt>AI</dt>
<dd><p>artificial
intelligence</p></dd>
<dt>Als3</dt>
<dd><p>agglutinin-like
sequences</p></dd>
<dt>COVID-19, EU</dt>
<dd><p>coronavirus disease 2019; European Union</p></dd>
<dt>Gwt1</dt>
<dd><p>cell wall transfer protein 1</p></dd>
<dt>Hsp90</dt>
<dd><p>heat shock protein
90</p></dd>
<dt>WHO</dt>
<dd><p>World Health
Organization</p></dd>
</dl></section><section id="notes-1"><p>CRediT: <strong>László Galgóczy</strong> conceptualization, funding
acquisition, visualization, writing - original draft, writing - review
&amp; editing.</p></section><section id="NOTES-d14e3089-autogenerated"><p>The author declares no
competing financial interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="ref1">
<cite>Fisher M. C., Gurr S. J., Cuomo C. A., Blehert D. S., Jin H., Stukenbrock E. H., Stajich J. E., Kahmann R., Boone C., Denning D. W., Gow N. A. R., Klein B. S., Kronstad J. W., Sheppard D. C., Taylor J. W., Wright G. D., Heitman J., Casadevall A., Cowen L. E.. Threats posed by the fungal kingdom
to humans, wildlife, and agriculture. mBio. 2020;11(3):e00449-20.  doi: 10.1128/mBio.00449-20.</cite> [<a href="https://doi.org/10.1128/mBio.00449-20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7403777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32371596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=mBio&amp;title=Threats%20posed%20by%20the%20fungal%20kingdom%20to%20humans,%20wildlife,%20and%20agriculture&amp;author=M.%20C.%20Fisher&amp;author=S.%20J.%20Gurr&amp;author=C.%20A.%20Cuomo&amp;author=D.%20S.%20Blehert&amp;author=H.%20Jin&amp;volume=11&amp;issue=3&amp;publication_year=2020&amp;pages=e00449-20&amp;pmid=32371596&amp;doi=10.1128/mBio.00449-20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<cite>Kainz K., Bauer M. A., Madeo F., Carmona-Gutierrez D.. Fungal infections
in humans: the silent crisis. Microb. Cell. 2020;7(6):143–145. doi: 10.15698/mic2020.06.718.</cite> [<a href="https://doi.org/10.15698/mic2020.06.718" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7278517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32548176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microb.%20Cell&amp;title=Fungal%20infections%20in%20humans:%20the%20silent%20crisis&amp;author=K.%20Kainz&amp;author=M.%20A.%20Bauer&amp;author=F.%20Madeo&amp;author=D.%20Carmona-Gutierrez&amp;volume=7&amp;issue=6&amp;publication_year=2020&amp;pages=143-145&amp;pmid=32548176&amp;doi=10.15698/mic2020.06.718&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<cite>Denning D. W.. Global
incidence and mortality of severe fungal disease. Lancet Infect. Dis. 2024;24(5):e428–e438. doi: 10.1016/S1473-3099(23)00692-8.</cite> [<a href="https://doi.org/10.1016/S1473-3099(23)00692-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38224705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect.%20Dis.&amp;title=Global%20incidence%20and%20mortality%20of%20severe%20fungal%20disease&amp;author=D.%20W.%20Denning&amp;volume=24&amp;issue=5&amp;publication_year=2024&amp;pages=e428-e438&amp;pmid=38224705&amp;doi=10.1016/S1473-3099(23)00692-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<cite>Ikuta K. S., Meštrovićm T., Naghavi M.. Global incidence and
mortality of severe fungal disease. Lancet Infect.
Dis. 2024;24(5):e268.  doi: 10.1016/S1473-3099(24)00102-6.</cite> [<a href="https://doi.org/10.1016/S1473-3099(24)00102-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38395046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect.%20Dis.&amp;title=Global%20incidence%20and%20mortality%20of%20severe%20fungal%20disease&amp;author=K.%20S.%20Ikuta&amp;author=T.%20Me%C5%A1trovi%C4%87m&amp;author=M.%20Naghavi&amp;volume=24&amp;issue=5&amp;publication_year=2024&amp;pages=e268&amp;pmid=38395046&amp;doi=10.1016/S1473-3099(24)00102-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<cite>Lass-Flörl C., Steixner S.. The changing epidemiology
of fungal infections. Mol. Aspects Med. 2023;94:101215.  doi: 10.1016/j.mam.2023.101215.</cite> [<a href="https://doi.org/10.1016/j.mam.2023.101215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37804792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Aspects%20Med.&amp;title=The%20changing%20epidemiology%20of%20fungal%20infections&amp;author=C.%20Lass-Fl%C3%B6rl&amp;author=S.%20Steixner&amp;volume=94&amp;publication_year=2023&amp;pages=101215&amp;pmid=37804792&amp;doi=10.1016/j.mam.2023.101215&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<cite>Spencer A. C., Brubaker K. R., Garneau-Tsodikova S.. Systemic fungal
infections: A pharmacist/researcher
perspective. Fungal Biol. Rev. 2023;44:100293.  doi: 10.1016/j.fbr.2022.11.001.</cite> [<a href="https://doi.org/10.1016/j.fbr.2022.11.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fungal%20Biol.%20Rev.&amp;title=Systemic%20fungal%20infections:%20A%20pharmacist/researcher%20perspective&amp;author=A.%20C.%20Spencer&amp;author=K.%20R.%20Brubaker&amp;author=S.%20Garneau-Tsodikova&amp;volume=44&amp;publication_year=2023&amp;pages=100293&amp;doi=10.1016/j.fbr.2022.11.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<cite>Reddy G. K. K., Padmavathi A. R., Nancharaiah Y. V.. Fungal
infections: Pathogenesis, antifungals and alternate treatment approaches. Curr. Res. Microb. Sci. 2022;3:100137.  doi: 10.1016/j.crmicr.2022.100137.</cite> [<a href="https://doi.org/10.1016/j.crmicr.2022.100137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9325902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35909631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Res.%20Microb.%20Sci.&amp;title=Fungal%20infections:%20Pathogenesis,%20antifungals%20and%20alternate%20treatment%20approaches&amp;author=G.%20K.%20K.%20Reddy&amp;author=A.%20R.%20Padmavathi&amp;author=Y.%20V.%20Nancharaiah&amp;volume=3&amp;publication_year=2022&amp;pages=100137&amp;pmid=35909631&amp;doi=10.1016/j.crmicr.2022.100137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<cite>Denning D. W.. Antifungal
drug resistance: an update. Eur. J. Hosp. Pharm. 2022;29(2):109–112. doi: 10.1136/ejhpharm-2020-002604.</cite> [<a href="https://doi.org/10.1136/ejhpharm-2020-002604" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8899664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35190454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hosp.%20Pharm.&amp;title=Antifungal%20drug%20resistance:%20an%20update&amp;author=D.%20W.%20Denning&amp;volume=29&amp;issue=2&amp;publication_year=2022&amp;pages=109-112&amp;pmid=35190454&amp;doi=10.1136/ejhpharm-2020-002604&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<cite>Rodrigues M. L., Nosanchukm J. D.. Fungal diseases as neglected pathogens: A wake-up call
to public health officials. PLoS Neglected Trop.
Dis. 2020;14(2):e0007964.  doi: 10.1371/journal.pntd.0007964.</cite> [<a href="https://doi.org/10.1371/journal.pntd.0007964" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7032689/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32078635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Neglected%20Trop.%20Dis.&amp;title=Fungal%20diseases%20as%20neglected%20pathogens:%20A%20wake-up%20call%20to%20public%20health%20officials&amp;author=M.%20L.%20Rodrigues&amp;author=J.%20D.%20Nosanchukm&amp;volume=14&amp;issue=2&amp;publication_year=2020&amp;pages=e0007964&amp;pmid=32078635&amp;doi=10.1371/journal.pntd.0007964&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<cite>
World Health Organization . WHO Fungal
Priority Pathogens List To Guide Research, Development
and Public Health Action, World Health Organization, 2022.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=WHO%20Fungal%20Priority%20Pathogens%20List%20To%20Guide%20Research,%20Development%20and%20Public%20Health%20Action&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<cite>Fisher M.
C., Denning D. W.. The WHO
fungal priority pathogens list as a game-changer. Nat. Rev. Microbiol. 2023;21(4):211–212. doi: 10.1038/s41579-023-00861-x.</cite> [<a href="https://doi.org/10.1038/s41579-023-00861-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9901396/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36747091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=The%20WHO%20fungal%20priority%20pathogens%20list%20as%20a%20game-changer&amp;author=M.%20C.%20Fisher&amp;author=D.%20W.%20Denning&amp;volume=21&amp;issue=4&amp;publication_year=2023&amp;pages=211-212&amp;pmid=36747091&amp;doi=10.1038/s41579-023-00861-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<cite>Benedict K., Whitham H. K., Jackson B. R.. Economic
burden of fungal diseases
in the United States. Open Forum Infect. Dis. 2022;9(4):ofac097.  doi: 10.1093/ofid/ofac097.</cite> [<a href="https://doi.org/10.1093/ofid/ofac097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8946773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35350173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Forum%20Infect.%20Dis.&amp;title=Economic%20burden%20of%20fungal%20diseases%20in%20the%20United%20States&amp;author=K.%20Benedict&amp;author=H.%20K.%20Whitham&amp;author=B.%20R.%20Jackson&amp;volume=9&amp;issue=4&amp;publication_year=2022&amp;pages=ofac097&amp;pmid=35350173&amp;doi=10.1093/ofid/ofac097&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<cite>Stukenbrock E., Gurr S.. Address the growing urgency of fungal
disease in crops. Nature. 2023;617(7959):31–34. doi: 10.1038/d41586-023-01465-4.</cite> [<a href="https://doi.org/10.1038/d41586-023-01465-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37130937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Address%20the%20growing%20urgency%20of%20fungal%20disease%20in%20crops&amp;author=E.%20Stukenbrock&amp;author=S.%20Gurr&amp;volume=617&amp;issue=7959&amp;publication_year=2023&amp;pages=31-34&amp;pmid=37130937&amp;doi=10.1038/d41586-023-01465-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<cite>

Searchinger, T.
; 
Waite, R.
; 
Hanson, C.
; 
Ranganathan, J.
; 
Matthews, E.
. 
Creating
a Sustainable
food future - A Menu of Solutions to Feed Nearly 10 billion People
by 2050, World Resources Institute, 2018.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Creating%20a%20Sustainable%20food%20future%20-%20A%20Menu%20of%20Solutions%20to%20Feed%20Nearly%2010%20billion%20People%20by%202050&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<cite>Brauer V.
S., Rezende C. P., Pessoni A. M., De Paula R. G., Rangappa K. S., Nayaka S. C., Gupta V. K., Almeida F.. Antifungal agents in
agriculture: Friends and foes of public health. Biomolecules. 2019;9(10):521. doi: 10.3390/biom9100521.</cite> [<a href="https://doi.org/10.3390/biom9100521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6843326/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31547546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=Antifungal%20agents%20in%20agriculture:%20Friends%20and%20foes%20of%20public%20health&amp;author=V.%20S.%20Brauer&amp;author=C.%20P.%20Rezende&amp;author=A.%20M.%20Pessoni&amp;author=R.%20G.%20De%20Paula&amp;author=K.%20S.%20Rangappa&amp;volume=9&amp;issue=10&amp;publication_year=2019&amp;pages=521&amp;pmid=31547546&amp;doi=10.3390/biom9100521&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref16">
<cite>Beckerman J., Palmer C., Tedford E., Ypema H.. Fifty years of fungicide
development, deployment, and future use. Phytopathology. 2023;113(4):694–706. doi: 10.1094/PHYTO-10-22-0399-IA.</cite> [<a href="https://doi.org/10.1094/PHYTO-10-22-0399-IA" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37137816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytopathology&amp;title=Fifty%20years%20of%20fungicide%20development,%20deployment,%20and%20future%20use&amp;author=J.%20Beckerman&amp;author=C.%20Palmer&amp;author=E.%20Tedford&amp;author=H.%20Ypema&amp;volume=113&amp;issue=4&amp;publication_year=2023&amp;pages=694-706&amp;pmid=37137816&amp;doi=10.1094/PHYTO-10-22-0399-IA&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref17">
<cite>Steinberg G., Gurr S. J.. Fungi, fungicide discovery and global food security. Fungal Genet. Biol. 2020;144:103476.  doi: 10.1016/j.fgb.2020.103476.</cite> [<a href="https://doi.org/10.1016/j.fgb.2020.103476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7755035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33053432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fungal%20Genet.%20Biol.&amp;title=Fungi,%20fungicide%20discovery%20and%20global%20food%20security&amp;author=G.%20Steinberg&amp;author=S.%20J.%20Gurr&amp;volume=144&amp;publication_year=2020&amp;pages=103476&amp;pmid=33053432&amp;doi=10.1016/j.fgb.2020.103476&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<cite>Marchand P. A.. EU chemical
plant protection products in 2023: Current state and perspectives. Agrochemicals. 2023;2:106–117. doi: 10.3390/agrochemicals2010008.</cite> [<a href="https://doi.org/10.3390/agrochemicals2010008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Agrochemicals&amp;title=EU%20chemical%20plant%20protection%20products%20in%202023:%20Current%20state%20and%20perspectives&amp;author=P.%20A.%20Marchand&amp;volume=2&amp;publication_year=2023&amp;pages=106-117&amp;doi=10.3390/agrochemicals2010008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19">
<cite>
European Commission . EU Action
Plan: ’Towards Zero Pollution for Air, Water and Soil, European Commission, 2021.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=EU%20Action%20Plan:%20%E2%80%99Towards%20Zero%20Pollution%20for%20Air,%20Water%20and%20Soil&amp;publication_year=2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref20">
<cite>Lobo
Vicente J., Ganzleben C., Gasol R., Marnane I., Gilles L., Buekers J., Bessems J., Colles A., Gerofke A., David M., Barouki R., Uhl M., Sepai O., Loots I., Crabbé A., Coertjens D., Kolossa-Gehring M., Schoeters G.. HBM4 EU results
support the Chemicals’ Strategy for Sustainability and the
Zero-Pollution Action Plan
. Int. J. Hyg. Environ. Health. 2023;248:114111.  doi: 10.1016/j.ijheh.2023.114111.</cite> [<a href="https://doi.org/10.1016/j.ijheh.2023.114111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36706581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Hyg.%20Environ.%20Health&amp;title=HBM4%20EU%20results%20support%20the%20Chemicals%E2%80%99%20Strategy%20for%20Sustainability%20and%20the%20Zero-Pollution%20Action%20Plan&amp;author=J.%20Lobo%20Vicente&amp;author=C.%20Ganzleben&amp;author=R.%20Gasol&amp;author=I.%20Marnane&amp;author=L.%20Gilles&amp;volume=248&amp;publication_year=2023&amp;pages=114111&amp;pmid=36706581&amp;doi=10.1016/j.ijheh.2023.114111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<cite>Robbins N., Wright G. D., Cowen L. E.. Antifungal drugs:
The current armamentarium
and development of new agents. Microbiol. Spectrum. 2016;4(5):10. doi: 10.1128/microbiolspec.FUNK-0002-2016.</cite> [<a href="https://doi.org/10.1128/microbiolspec.FUNK-0002-2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27763259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microbiol.%20Spectrum&amp;title=Antifungal%20drugs:%20The%20current%20armamentarium%20and%20development%20of%20new%20agents&amp;author=N.%20Robbins&amp;author=G.%20D.%20Wright&amp;author=L.%20E.%20Cowen&amp;volume=4&amp;issue=5&amp;publication_year=2016&amp;pages=10&amp;pmid=27763259&amp;doi=10.1128/microbiolspec.FUNK-0002-2016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22">
<cite>Perfect J. R.. The antifungal
pipeline: a reality check. Nat. Rev. Drug Discovery. 2017;16(9):603–616. doi: 10.1038/nrd.2017.46.</cite> [<a href="https://doi.org/10.1038/nrd.2017.46" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5760994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28496146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Drug%20Discovery&amp;title=The%20antifungal%20pipeline:%20a%20reality%20check&amp;author=J.%20R.%20Perfect&amp;volume=16&amp;issue=9&amp;publication_year=2017&amp;pages=603-616&amp;pmid=28496146&amp;doi=10.1038/nrd.2017.46&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref23">
<cite>Campoy S., Adrio J. L.. Antifungals. Biochem. Pharmacol. 2017;133:86–96. doi: 10.1016/j.bcp.2016.11.019.</cite> [<a href="https://doi.org/10.1016/j.bcp.2016.11.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27884742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Pharmacol.&amp;title=Antifungals&amp;author=S.%20Campoy&amp;author=J.%20L.%20Adrio&amp;volume=133&amp;publication_year=2017&amp;pages=86-96&amp;pmid=27884742&amp;doi=10.1016/j.bcp.2016.11.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24">
<cite>Nami S., Aghebati-Maleki A., Morovati H., Aghebati-Maleki L.. Current antifungal
drugs and immunotherapeutic approaches as promising strategies to
treatment of fungal diseases. Biomed. Pharmacother. 2019;110:857–868. doi: 10.1016/j.biopha.2018.12.009.</cite> [<a href="https://doi.org/10.1016/j.biopha.2018.12.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30557835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed.%20Pharmacother.&amp;title=Current%20antifungal%20drugs%20and%20immunotherapeutic%20approaches%20as%20promising%20strategies%20to%20treatment%20of%20fungal%20diseases&amp;author=S.%20Nami&amp;author=A.%20Aghebati-Maleki&amp;author=H.%20Morovati&amp;author=L.%20Aghebati-Maleki&amp;volume=110&amp;publication_year=2019&amp;pages=857-868&amp;pmid=30557835&amp;doi=10.1016/j.biopha.2018.12.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref25">
<cite>Van
Daele R., Spriet I., Wauters J., Maertens J., Mercier T., Van Hecke S., Brüggemann R.. Antifungal
drugs: What brings the future? Med. Mycol. 2019;57(S3):S328–S343. doi: 10.1093/mmy/myz012.</cite> [<a href="https://doi.org/10.1093/mmy/myz012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31292663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Mycol.&amp;title=Antifungal%20drugs:%20What%20brings%20the%20future?&amp;author=R.%20Van%20Daele&amp;author=I.%20Spriet&amp;author=J.%20Wauters&amp;author=J.%20Maertens&amp;author=T.%20Mercier&amp;volume=57&amp;issue=S3&amp;publication_year=2019&amp;pages=S328-S343&amp;pmid=31292663&amp;doi=10.1093/mmy/myz012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<cite>Arastehfar A., Gabaldón T., Garcia-Rubio R., Jenks J. D., Hoenigl M., Salzer H. J. F., Ilkit M., Lass-Flörl C., Perlin D. S.. Drug-resistant fungi:
An emerging challenge threatening
our limited antifungal armamentarium. Antibiotics. 2020;9(12):877. doi: 10.3390/antibiotics9120877.</cite> [<a href="https://doi.org/10.3390/antibiotics9120877" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7764418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33302565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antibiotics&amp;title=Drug-resistant%20fungi:%20An%20emerging%20challenge%20threatening%20our%20limited%20antifungal%20armamentarium&amp;author=A.%20Arastehfar&amp;author=T.%20Gabald%C3%B3n&amp;author=R.%20Garcia-Rubio&amp;author=J.%20D.%20Jenks&amp;author=M.%20Hoenigl&amp;volume=9&amp;issue=12&amp;publication_year=2020&amp;pages=877&amp;pmid=33302565&amp;doi=10.3390/antibiotics9120877&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref27">
<cite>Houšt’ J., Spížek J., Havlíček V.. Antifungal drugs. Metabolites. 2020;10(3):106. doi: 10.3390/metabo10030106.</cite> [<a href="https://doi.org/10.3390/metabo10030106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7143493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32178468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolites&amp;title=Antifungal%20drugs&amp;author=J.%20Hou%C5%A1t%E2%80%99&amp;author=J.%20Sp%C3%AD%C5%BEek&amp;author=V.%20Havl%C3%AD%C4%8Dek&amp;volume=10&amp;issue=3&amp;publication_year=2020&amp;pages=106&amp;pmid=32178468&amp;doi=10.3390/metabo10030106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref28">
<cite>Vanreppelen G., Wuyts J., Van Dijck P., Vandecruys P.. Sources of
antifungal drugs. J. Fungi. 2023;9(2):171. doi: 10.3390/jof9020171.</cite> [<a href="https://doi.org/10.3390/jof9020171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9965926/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36836286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Sources%20of%20antifungal%20drugs&amp;author=G.%20Vanreppelen&amp;author=J.%20Wuyts&amp;author=P.%20Van%20Dijck&amp;author=P.%20Vandecruys&amp;volume=9&amp;issue=2&amp;publication_year=2023&amp;pages=171&amp;pmid=36836286&amp;doi=10.3390/jof9020171&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref29">
<cite>Souza C. M. d., Bezerra B. T., Mellon D. A., de Oliveira H. C.. The evolution
of antifungal therapy: Traditional agents, current challenges and
future perspectives. Curr. Res. Microb. Sci. 2025;8:100341.  doi: 10.1016/j.crmicr.2025.100341.</cite> [<a href="https://doi.org/10.1016/j.crmicr.2025.100341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11786858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39897698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Res.%20Microb.%20Sci.&amp;title=The%20evolution%20of%20antifungal%20therapy:%20Traditional%20agents,%20current%20challenges%20and%20future%20perspectives&amp;author=C.%20M.%20d.%20Souza&amp;author=B.%20T.%20Bezerra&amp;author=D.%20A.%20Mellon&amp;author=H.%20C.%20de%20Oliveira&amp;volume=8&amp;publication_year=2025&amp;pages=100341&amp;pmid=39897698&amp;doi=10.1016/j.crmicr.2025.100341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref30">
<cite>Saini V., Safwan S. M., Mehta D., Das E. E., Bajaj A.. Recent advances
in the development of antifungal agents: Beyond azoles, polyenes,
and echinocandins. ACS Infect. Dis. 2025;11:1271. doi: 10.1021/acsinfecdis.4c00828.</cite> [<a href="https://doi.org/10.1021/acsinfecdis.4c00828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40358027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect.%20Dis.&amp;title=Recent%20advances%20in%20the%20development%20of%20antifungal%20agents:%20Beyond%20azoles,%20polyenes,%20and%20echinocandins&amp;author=V.%20Saini&amp;author=S.%20M.%20Safwan&amp;author=D.%20Mehta&amp;author=E.%20E.%20Das&amp;author=A.%20Bajaj&amp;volume=11&amp;publication_year=2025&amp;pages=1271&amp;pmid=40358027&amp;doi=10.1021/acsinfecdis.4c00828&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref31">
<cite>Sousa F., Ferreira D., Reis S., Costa P.. Current insights on
antifungal therapy: Novel nanotechnology approaches for drug delivery
systems and new drugs from natural sources. Pharmaceuticals. 2020;13(9):248. doi: 10.3390/ph13090248.</cite> [<a href="https://doi.org/10.3390/ph13090248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7558771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32942693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Current%20insights%20on%20antifungal%20therapy:%20Novel%20nanotechnology%20approaches%20for%20drug%20delivery%20systems%20and%20new%20drugs%20from%20natural%20sources&amp;author=F.%20Sousa&amp;author=D.%20Ferreira&amp;author=S.%20Reis&amp;author=P.%20Costa&amp;volume=13&amp;issue=9&amp;publication_year=2020&amp;pages=248&amp;pmid=32942693&amp;doi=10.3390/ph13090248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref32">
<cite>Carmo A., Rocha M., Pereirinha P., Tomé R., Costa E.. Antifungals: From Pharmacokinetics to Clinical Practice. Antibiotics. 2023;12(5):884. doi: 10.3390/antibiotics12050884.</cite> [<a href="https://doi.org/10.3390/antibiotics12050884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10215229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37237787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antibiotics&amp;title=Antifungals:%20From%20Pharmacokinetics%20to%20Clinical%20Practice&amp;author=A.%20Carmo&amp;author=M.%20Rocha&amp;author=P.%20Pereirinha&amp;author=R.%20Tom%C3%A9&amp;author=E.%20Costa&amp;volume=12&amp;issue=5&amp;publication_year=2023&amp;pages=884&amp;pmid=37237787&amp;doi=10.3390/antibiotics12050884&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref33">
<cite>Wall G., Lopez-Ribot J. L.. Current antimycotics, new prospects,
and future approaches
to antifungal therapy. Antibiotics. 2020;9(8):445. doi: 10.3390/antibiotics9080445.</cite> [<a href="https://doi.org/10.3390/antibiotics9080445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7460292/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32722455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antibiotics&amp;title=Current%20antimycotics,%20new%20prospects,%20and%20future%20approaches%20to%20antifungal%20therapy&amp;author=G.%20Wall&amp;author=J.%20L.%20Lopez-Ribot&amp;volume=9&amp;issue=8&amp;publication_year=2020&amp;pages=445&amp;pmid=32722455&amp;doi=10.3390/antibiotics9080445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref34">
<cite>Delma F. Z., Al-Hatmi A. M. S., Brüggemann R.
J. M., Melchers W. J. G., de Hoog S., Verweij P. E., Buil J. B.. Molecular mechanisms
of 5-fluorocytosine resistance in yeasts and filamentous fungi. J. Fungi. 2021;7(11):909. doi: 10.3390/jof7110909.</cite> [<a href="https://doi.org/10.3390/jof7110909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8623157/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34829198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Molecular%20mechanisms%20of%205-fluorocytosine%20resistance%20in%20yeasts%20and%20filamentous%20fungi&amp;author=F.%20Z.%20Delma&amp;author=A.%20M.%20S.%20Al-Hatmi&amp;author=R.%20J.%20M.%20Br%C3%BCggemann&amp;author=W.%20J.%20G.%20Melchers&amp;author=S.%20de%20Hoog&amp;volume=7&amp;issue=11&amp;publication_year=2021&amp;pages=909&amp;pmid=34829198&amp;doi=10.3390/jof7110909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref35">
<cite>Bouz G., Doležal M.. Advances in antifungal drug development: An up-to-date
mini review. Pharmaceuticals. 2021;14(12):1312. doi: 10.3390/ph14121312.</cite> [<a href="https://doi.org/10.3390/ph14121312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8706862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34959712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Advances%20in%20antifungal%20drug%20development:%20An%20up-to-date%20mini%20review&amp;author=G.%20Bouz&amp;author=M.%20Dole%C5%BEal&amp;volume=14&amp;issue=12&amp;publication_year=2021&amp;pages=1312&amp;pmid=34959712&amp;doi=10.3390/ph14121312&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref36">
<cite>Lee A.. Ibrexafungerp:
First approval. Drugs. 2021;81(12):1445–1450. doi: 10.1007/s40265-021-01571-5.</cite> [<a href="https://doi.org/10.1007/s40265-021-01571-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34313977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Ibrexafungerp:%20First%20approval&amp;author=A.%20Lee&amp;volume=81&amp;issue=12&amp;publication_year=2021&amp;pages=1445-1450&amp;pmid=34313977&amp;doi=10.1007/s40265-021-01571-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref37">
<cite>Hoy S. M.. Oteseconazole:
First approval. Drugs. 2022;82(9):1017–1023. doi: 10.1007/s40265-022-01734-y.</cite> [<a href="https://doi.org/10.1007/s40265-022-01734-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35713845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Oteseconazole:%20First%20approval&amp;author=S.%20M.%20Hoy&amp;volume=82&amp;issue=9&amp;publication_year=2022&amp;pages=1017-1023&amp;pmid=35713845&amp;doi=10.1007/s40265-022-01734-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref38">
<cite>Syed Y. Y.. Rezafungin:
First approval. Drugs. 2023;83(9):833–840. doi: 10.1007/s40265-023-01891-8.</cite> [<a href="https://doi.org/10.1007/s40265-023-01891-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37212966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Rezafungin:%20First%20approval&amp;author=Y.%20Y.%20Syed&amp;volume=83&amp;issue=9&amp;publication_year=2023&amp;pages=833-840&amp;pmid=37212966&amp;doi=10.1007/s40265-023-01891-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref39">
<cite>Fisher M. C., Alastruey-Izquierdo A., Berman J., Bicanic T., Bignell E. M., Bowyer P., Bromley M., Brüggemann R., Garber G., Cornely O. A., Gurr S. J., Harrison T. S., Kuijper E., Rhodes J., Sheppard D. C., Warris A., White P. L., Xu J., Zwaan B., Verweij P. E.. Tackling
the emerging threat of antifungal resistance to human health. Nat. Rev. Microbiol. 2022;20(9):557–571. doi: 10.1038/s41579-022-00720-1.</cite> [<a href="https://doi.org/10.1038/s41579-022-00720-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8962932/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35352028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=Tackling%20the%20emerging%20threat%20of%20antifungal%20resistance%20to%20human%20health&amp;author=M.%20C.%20Fisher&amp;author=A.%20Alastruey-Izquierdo&amp;author=J.%20Berman&amp;author=T.%20Bicanic&amp;author=E.%20M.%20Bignell&amp;volume=20&amp;issue=9&amp;publication_year=2022&amp;pages=557-571&amp;pmid=35352028&amp;doi=10.1038/s41579-022-00720-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref40">
<cite>Zobi C., Algul O.. The Significance of
mono- and dual-effective agents in the development
of new antifungal strategies. Chem. Biol. Drug
Des. 2025;105(1):e70045.  doi: 10.1111/cbdd.70045.</cite> [<a href="https://doi.org/10.1111/cbdd.70045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11753615/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39841631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Biol.%20Drug%20Des.&amp;title=The%20Significance%20of%20mono-%20and%20dual-effective%20agents%20in%20the%20development%20of%20new%20antifungal%20strategies&amp;author=C.%20Zobi&amp;author=O.%20Algul&amp;volume=105&amp;issue=1&amp;publication_year=2025&amp;pages=e70045&amp;pmid=39841631&amp;doi=10.1111/cbdd.70045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref41">
<cite>Puumala E., Fallah S., Robbins N., Cowen L. E.. Advancements and
challenges in antifungal therapeutic development. Clin. Microbiol. Rev. 2024;37(1):e0014223.  doi: 10.1128/cmr.00142-23.</cite> [<a href="https://doi.org/10.1128/cmr.00142-23" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10938895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38294218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Microbiol.%20Rev.&amp;title=Advancements%20and%20challenges%20in%20antifungal%20therapeutic%20development&amp;author=E.%20Puumala&amp;author=S.%20Fallah&amp;author=N.%20Robbins&amp;author=L.%20E.%20Cowen&amp;volume=37&amp;issue=1&amp;publication_year=2024&amp;pages=e0014223&amp;pmid=38294218&amp;doi=10.1128/cmr.00142-23&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref42">
<cite>Nnadi N. E., Carter D. A.. Climate change and the emergence of fungal pathogens. PLoS Pathog. 2021;17(4):e1009503.  doi: 10.1371/journal.ppat.1009503.</cite> [<a href="https://doi.org/10.1371/journal.ppat.1009503" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8084208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33914854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Pathog.&amp;title=Climate%20change%20and%20the%20emergence%20of%20fungal%20pathogens&amp;author=N.%20E.%20Nnadi&amp;author=D.%20A.%20Carter&amp;volume=17&amp;issue=4&amp;publication_year=2021&amp;pages=e1009503&amp;pmid=33914854&amp;doi=10.1371/journal.ppat.1009503&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref43">
<cite>Smith D. J., Gold J. A. W., Benedict K., Wu K., Lyman M., Jordan A., Medina N., Lockhart S. R., Sexton D. J., Chow N. A., Jackson B. R., Litvintseva A. P., Toda M., Chiller T.. Public health research priorities
for fungal diseases: A multidisciplinary approach to save lives. J. Fungi. 2023;9(8):820. doi: 10.3390/jof9080820.</cite> [<a href="https://doi.org/10.3390/jof9080820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10455901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37623591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Public%20health%20research%20priorities%20for%20fungal%20diseases:%20A%20multidisciplinary%20approach%20to%20save%20lives&amp;author=D.%20J.%20Smith&amp;author=J.%20A.%20W.%20Gold&amp;author=K.%20Benedict&amp;author=K.%20Wu&amp;author=M.%20Lyman&amp;volume=9&amp;issue=8&amp;publication_year=2023&amp;pages=820&amp;pmid=37623591&amp;doi=10.3390/jof9080820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref44">
<cite>Lockhart S. R., Chowdhary A., Gold J. A. W.. The rapid emergence of antifungal-resistant
human-pathogenic fungi. Nat. Rev. Microbiol. 2023;21(12):818–832. doi: 10.1038/s41579-023-00960-9.</cite> [<a href="https://doi.org/10.1038/s41579-023-00960-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10859884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37648790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=The%20rapid%20emergence%20of%20antifungal-resistant%20human-pathogenic%20fungi&amp;author=S.%20R.%20Lockhart&amp;author=A.%20Chowdhary&amp;author=J.%20A.%20W.%20Gold&amp;volume=21&amp;issue=12&amp;publication_year=2023&amp;pages=818-832&amp;pmid=37648790&amp;doi=10.1038/s41579-023-00960-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref45">
<cite>Langfeldt A., Gold J. A. W., Chiller T.. Emerging fungal infections: from
the fields to the clinic, resistant Aspergillus fumigatus and dermatophyte species: a one health perspective on an urgent
public health problem. Curr. Clin. Microbiol.
Rep. 2022;9(4):46–51. doi: 10.1007/s40588-022-00181-3.</cite> [<a href="https://doi.org/10.1007/s40588-022-00181-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9512973/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36188157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Clin.%20Microbiol.%20Rep.&amp;title=Emerging%20fungal%20infections:%20from%20the%20fields%20to%20the%20clinic,%20resistant%20Aspergillus%20fumigatus%20and%20dermatophyte%20species:%20a%20one%20health%20perspective%20on%20an%20urgent%20public%20health%20problem&amp;author=A.%20Langfeldt&amp;author=J.%20A.%20W.%20Gold&amp;author=T.%20Chiller&amp;volume=9&amp;issue=4&amp;publication_year=2022&amp;pages=46-51&amp;pmid=36188157&amp;doi=10.1007/s40588-022-00181-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref46">
<cite>Perlin D. S., Rautemaa-Richardson R., Alastruey-Izquierdo A.. The global
problem of antifungal
resistance: prevalence, mechanisms, and management. Lancet Infect. Dis. 2017;17(12):e383–e392. doi: 10.1016/S1473-3099(17)30316-X.</cite> [<a href="https://doi.org/10.1016/S1473-3099(17)30316-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28774698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect.%20Dis.&amp;title=The%20global%20problem%20of%20antifungal%20resistance:%20prevalence,%20mechanisms,%20and%20management&amp;author=D.%20S.%20Perlin&amp;author=R.%20Rautemaa-Richardson&amp;author=A.%20Alastruey-Izquierdo&amp;volume=17&amp;issue=12&amp;publication_year=2017&amp;pages=e383-e392&amp;pmid=28774698&amp;doi=10.1016/S1473-3099(17)30316-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref47">
<cite>Vincent B. M., Lancaster A. K., Scherz-Shouval R., Whitesell L., Lindquist S.. Fitness trade-offs
restrict the evolution of resistance
to amphotericin B. PLoS Biol. 2013;11(10):e1001692.  doi: 10.1371/journal.pbio.1001692.</cite> [<a href="https://doi.org/10.1371/journal.pbio.1001692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3812114/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24204207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Biol.&amp;title=Fitness%20trade-offs%20restrict%20the%20evolution%20of%20resistance%20to%20amphotericin%20B&amp;author=B.%20M.%20Vincent&amp;author=A.%20K.%20Lancaster&amp;author=R.%20Scherz-Shouval&amp;author=L.%20Whitesell&amp;author=S.%20Lindquist&amp;volume=11&amp;issue=10&amp;publication_year=2013&amp;pages=e1001692&amp;pmid=24204207&amp;doi=10.1371/journal.pbio.1001692&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref48">
<cite>Carolus H., Pierson S., Lagrou K., Van Dijck P.. Amphotericin
B and other polyenes-discovery, clinical use, mode of action and drug
resistance. J. Fungi. 2020;6(4):321. doi: 10.3390/jof6040321.</cite> [<a href="https://doi.org/10.3390/jof6040321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7724567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33261213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Amphotericin%20B%20and%20other%20polyenes-discovery,%20clinical%20use,%20mode%20of%20action%20and%20drug%20resistance&amp;author=H.%20Carolus&amp;author=S.%20Pierson&amp;author=K.%20Lagrou&amp;author=P.%20Van%20Dijck&amp;volume=6&amp;issue=4&amp;publication_year=2020&amp;pages=321&amp;pmid=33261213&amp;doi=10.3390/jof6040321&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref49">
<cite>Martinez-Rossi N. M., Peres N. T. A., Bitencourt T. A., Martins M. P., Rossi A.. State-of-the-art
dermatophyte infections: Epidemiology aspects, pathophysiology, and
resistance mechanisms. J. Fungi. 2021;7(8):629. doi: 10.3390/jof7080629.</cite> [<a href="https://doi.org/10.3390/jof7080629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8401872/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34436168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=State-of-the-art%20dermatophyte%20infections:%20Epidemiology%20aspects,%20pathophysiology,%20and%20resistance%20mechanisms&amp;author=N.%20M.%20Martinez-Rossi&amp;author=N.%20T.%20A.%20Peres&amp;author=T.%20A.%20Bitencourt&amp;author=M.%20P.%20Martins&amp;author=A.%20Rossi&amp;volume=7&amp;issue=8&amp;publication_year=2021&amp;pages=629&amp;pmid=34436168&amp;doi=10.3390/jof7080629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref50">
<cite>El
Ayoubi L. W., Allaw F., Moussa E., Kanj S. S.. Ibrexafungerp:
A narrative overview. Curr. Res. Microb. Sci. 2024;6:100245.  doi: 10.1016/j.crmicr.2024.100245.</cite> [<a href="https://doi.org/10.1016/j.crmicr.2024.100245" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11170096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38873590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Res.%20Microb.%20Sci.&amp;title=Ibrexafungerp:%20A%20narrative%20overview&amp;author=L.%20W.%20El%20Ayoubi&amp;author=F.%20Allaw&amp;author=E.%20Moussa&amp;author=S.%20S.%20Kanj&amp;volume=6&amp;publication_year=2024&amp;pages=100245&amp;pmid=38873590&amp;doi=10.1016/j.crmicr.2024.100245&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref51">
<cite>

Fox, E. P.
; 
Singh-Babak, S. D.
; 
Hartooni, N.
; 
Nobile, C. J.
. 
Biofilms and
Antifungal Resistance. In Antifungals: From
Genomics to Resistance and the Development of Novel Agents; 
Coste, A. T.
; 
Vandeputte, P.
, Eds.; Caister Academic Press: Poole, 2015; pp 71–90.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Antifungals:%20From%20Genomics%20to%20Resistance%20and%20the%20Development%20of%20Novel%20Agents&amp;publication_year=2015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref52">
<cite>Borghi E., Borgo F., Morace G.. Fungal biofilms:
Update on resistance. Adv. Exp. Med. Biol. 2016;931:37–47. doi: 10.1007/5584_2016_7.</cite> [<a href="https://doi.org/10.1007/5584_2016_7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27115411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Exp.%20Med.%20Biol.&amp;title=Fungal%20biofilms:%20Update%20on%20resistance&amp;author=E.%20Borghi&amp;author=F.%20Borgo&amp;author=G.%20Morace&amp;volume=931&amp;publication_year=2016&amp;pages=37-47&amp;pmid=27115411&amp;doi=10.1007/5584_2016_7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref53">
<cite>Fuentefria A. M., Pippi B., Dalla Lana D. F., Donato K. K., de Andrade S. F.. Antifungals
discovery: an insight into new strategies to combat antifungal resistance. Lett. Appl. Microbiol. 2018;66(1):2–13. doi: 10.1111/lam.12820.</cite> [<a href="https://doi.org/10.1111/lam.12820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29112282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lett.%20Appl.%20Microbiol.&amp;title=Antifungals%20discovery:%20an%20insight%20into%20new%20strategies%20to%20combat%20antifungal%20resistance&amp;author=A.%20M.%20Fuentefria&amp;author=B.%20Pippi&amp;author=D.%20F.%20Dalla%20Lana&amp;author=K.%20K.%20Donato&amp;author=S.%20F.%20de%20Andrade&amp;volume=66&amp;issue=1&amp;publication_year=2018&amp;pages=2-13&amp;pmid=29112282&amp;doi=10.1111/lam.12820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref54">
<cite>Rosenberg A., Ene I. V., Bibi M., Zakin S., Segal E. S., Ziv N., Dahan A. M., Colombo A. L., Bennett R. J., Berman J.. Antifungal
tolerance is a subpopulation effect distinct from resistance and is
associated with persistent candidemia. Nat.
Commun. 2018;9(1):2470.  doi: 10.1038/s41467-018-04926-x.</cite> [<a href="https://doi.org/10.1038/s41467-018-04926-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6018213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29941885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Antifungal%20tolerance%20is%20a%20subpopulation%20effect%20distinct%20from%20resistance%20and%20is%20associated%20with%20persistent%20candidemia&amp;author=A.%20Rosenberg&amp;author=I.%20V.%20Ene&amp;author=M.%20Bibi&amp;author=S.%20Zakin&amp;author=E.%20S.%20Segal&amp;volume=9&amp;issue=1&amp;publication_year=2018&amp;pages=2470&amp;pmid=29941885&amp;doi=10.1038/s41467-018-04926-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref55">
<cite>Chen L., Tian X., Zhang L., Wang W., Hu P., Ma Z., Li Y., Li S., Shen Z., Fan X., Ye L., Ke W., Wu Y., Shui G., Xiao M., He G. J., Yang Y., Fang W., Bai F., Liao G., Chen M., Lin X., Li C., Wang L.. Brain glucose induces tolerance of Cryptococcus neoformans to amphotericin B during meningitis. Nat.
Microbiol. 2024;9(2):346–358. doi: 10.1038/s41564-023-01561-1.</cite> [<a href="https://doi.org/10.1038/s41564-023-01561-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38225460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Microbiol.&amp;title=Brain%20glucose%20induces%20tolerance%20of%20Cryptococcus%20neoformans%20to%20amphotericin%20B%20during%20meningitis&amp;author=L.%20Chen&amp;author=X.%20Tian&amp;author=L.%20Zhang&amp;author=W.%20Wang&amp;author=P.%20Hu&amp;volume=9&amp;issue=2&amp;publication_year=2024&amp;pages=346-358&amp;pmid=38225460&amp;doi=10.1038/s41564-023-01561-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref56">
<cite>Ke W., Xie Y., Chen Y., Ding H., Ye L., Qiu H., Li H., Zhang L., Chen L., Tian X., Shen Z., Song Z., Fan X., Zong J. F., Guo Z., Ma X., Xiao M., Liao G., Liu C. H., Yin W. B., Dong Z., Yang F., Jiang Y. Y., Perlin D. S., Chen Y., Fu Y. V., Wang L.. Fungicide-tolerant
persister formation during cryptococcal pulmonary infection. Cell Host Microbe. 2024;32(2):276–289.e7. doi: 10.1016/j.chom.2023.12.012.</cite> [<a href="https://doi.org/10.1016/j.chom.2023.12.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38215741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Host%20Microbe&amp;title=Fungicide-tolerant%20persister%20formation%20during%20cryptococcal%20pulmonary%20infection&amp;author=W.%20Ke&amp;author=Y.%20Xie&amp;author=Y.%20Chen&amp;author=H.%20Ding&amp;author=L.%20Ye&amp;volume=32&amp;issue=2&amp;publication_year=2024&amp;pages=276-289.e7&amp;pmid=38215741&amp;doi=10.1016/j.chom.2023.12.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref57">
<cite>Yang Y. L., Xiang Z. J., Yang J. H., Wang W. J., Xu Z. C., Xiang R. L.. Adverse effects associated with currently
commonly
used antifungal agents: A network meta-analysis and systematic review. Front. Pharmacol. 2021;12:697330.  doi: 10.3389/fphar.2021.697330.</cite> [<a href="https://doi.org/10.3389/fphar.2021.697330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8585744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34776941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=Adverse%20effects%20associated%20with%20currently%20commonly%20used%20antifungal%20agents:%20A%20network%20meta-analysis%20and%20systematic%20review&amp;author=Y.%20L.%20Yang&amp;author=Z.%20J.%20Xiang&amp;author=J.%20H.%20Yang&amp;author=W.%20J.%20Wang&amp;author=Z.%20C.%20Xu&amp;volume=12&amp;publication_year=2021&amp;pages=697330&amp;pmid=34776941&amp;doi=10.3389/fphar.2021.697330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref58">
<cite>Mazzei T., Novelli A.. Pharmacological properties of antifungal
drugs with
a focus on anidulafungin. Drugs. 2009;69(Suppl 1):79–90. doi: 10.2165/11315550-000000000-00000.</cite> [<a href="https://doi.org/10.2165/11315550-000000000-00000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19877739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Pharmacological%20properties%20of%20antifungal%20drugs%20with%20a%20focus%20on%20anidulafungin&amp;author=T.%20Mazzei&amp;author=A.%20Novelli&amp;volume=69&amp;issue=Suppl%201&amp;publication_year=2009&amp;pages=79-90&amp;pmid=19877739&amp;doi=10.2165/11315550-000000000-00000&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref59">
<cite>Lepak A. J., Andes D. R.. Antifungal pharmacokinetics
and pharmacodynamics. Cold Spring Harbor Perspect.
Med. 2015;5(5):a019653.  doi: 10.1101/cshperspect.a019653.</cite> [<a href="https://doi.org/10.1101/cshperspect.a019653" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4448584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25384765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harbor%20Perspect.%20Med.&amp;title=Antifungal%20pharmacokinetics%20and%20pharmacodynamics&amp;author=A.%20J.%20Lepak&amp;author=D.%20R.%20Andes&amp;volume=5&amp;issue=5&amp;publication_year=2015&amp;pages=a019653&amp;pmid=25384765&amp;doi=10.1101/cshperspect.a019653&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref60">
<cite>Ashley E. D.. Antifungal
drugs: Special problems treating central nervous system infections. J. Fungi. 2019;5(4):97. doi: 10.3390/jof5040097.</cite> [<a href="https://doi.org/10.3390/jof5040097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6958367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31614505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Antifungal%20drugs:%20Special%20problems%20treating%20central%20nervous%20system%20infections&amp;author=E.%20D.%20Ashley&amp;volume=5&amp;issue=4&amp;publication_year=2019&amp;pages=97&amp;pmid=31614505&amp;doi=10.3390/jof5040097&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref61">
<cite>Wirth F., Ishida K.. Antifungal drugs: An updated review of central nervous
system pharmacokinetics. Mycoses. 2020;63(10):1047–1059. doi: 10.1111/myc.13157.</cite> [<a href="https://doi.org/10.1111/myc.13157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32772402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mycoses&amp;title=Antifungal%20drugs:%20An%20updated%20review%20of%20central%20nervous%20system%20pharmacokinetics&amp;author=F.%20Wirth&amp;author=K.%20Ishida&amp;volume=63&amp;issue=10&amp;publication_year=2020&amp;pages=1047-1059&amp;pmid=32772402&amp;doi=10.1111/myc.13157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref62">
<cite>Góralska K., Blaszkowska J., Dzikowiec M.. Neuroinfections caused by fungi. Infection. 2018;46(4):443–459. doi: 10.1007/s15010-018-1152-2.</cite> [<a href="https://doi.org/10.1007/s15010-018-1152-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6096918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29785613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Infection&amp;title=Neuroinfections%20caused%20by%20fungi&amp;author=K.%20G%C3%B3ralska&amp;author=J.%20Blaszkowska&amp;author=M.%20Dzikowiec&amp;volume=46&amp;issue=4&amp;publication_year=2018&amp;pages=443-459&amp;pmid=29785613&amp;doi=10.1007/s15010-018-1152-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref63">
<cite>Tillotson J., Tillotson G. S.. The regulatory pathway for antifungal
drugs: A US perspective. Clin. Infect. Dis. 2015;61(Suppl 6):S678–S683. doi: 10.1093/cid/civ819.</cite> [<a href="https://doi.org/10.1093/cid/civ819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26567287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Infect.%20Dis.&amp;title=The%20regulatory%20pathway%20for%20antifungal%20drugs:%20A%20US%20perspective&amp;author=J.%20Tillotson&amp;author=G.%20S.%20Tillotson&amp;volume=61&amp;issue=Suppl%206&amp;publication_year=2015&amp;pages=S678-S683&amp;pmid=26567287&amp;doi=10.1093/cid/civ819&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref64">
<cite>Wall G., Lopez-Ribot J. L.. Screening
repurposing libraries for identification
of drugs with novel antifungal activity. Antimicrob.
Agents Chemother. 2020;64(9):e00924-20.  doi: 10.1128/AAC.00924-20.</cite> [<a href="https://doi.org/10.1128/AAC.00924-20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7449171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32660991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob.%20Agents%20Chemother.&amp;title=Screening%20repurposing%20libraries%20for%20identification%20of%20drugs%20with%20novel%20antifungal%20activity&amp;author=G.%20Wall&amp;author=J.%20L.%20Lopez-Ribot&amp;volume=64&amp;issue=9&amp;publication_year=2020&amp;pages=e00924-20&amp;pmid=32660991&amp;doi=10.1128/AAC.00924-20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref65">
<cite>Kneale M., Bartholomew J. S., Davies E., Denning D. W.. Global access to
antifungal therapy and its variable cost. J.
Antimicrob. Chemother. 2016;71(12):3599–3606. doi: 10.1093/jac/dkw325.</cite> [<a href="https://doi.org/10.1093/jac/dkw325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27516477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Antimicrob.%20Chemother.&amp;title=Global%20access%20to%20antifungal%20therapy%20and%20its%20variable%20cost&amp;author=M.%20Kneale&amp;author=J.%20S.%20Bartholomew&amp;author=E.%20Davies&amp;author=D.%20W.%20Denning&amp;volume=71&amp;issue=12&amp;publication_year=2016&amp;pages=3599-3606&amp;pmid=27516477&amp;doi=10.1093/jac/dkw325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref66">
<cite>Riera F., Caeiro J. P., Sotomayor C. E.. Antifungal
stewardship in low- and
middle-income countries. Curr. Treat. Options
Infect. Dis. 2019;11:292–299. doi: 10.1007/s40506-019-00197-2.</cite> [<a href="https://doi.org/10.1007/s40506-019-00197-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Treat.%20Options%20Infect.%20Dis.&amp;title=Antifungal%20stewardship%20in%20low-%20and%20middle-income%20countries&amp;author=F.%20Riera&amp;author=J.%20P.%20Caeiro&amp;author=C.%20E.%20Sotomayor&amp;volume=11&amp;publication_year=2019&amp;pages=292-299&amp;doi=10.1007/s40506-019-00197-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref67">
<cite>de
Oliveira H. C., Bezerra B. T., Rodrigues M. L.. Antifungal
development and the urgency of minimizing the impact of fungal diseases
on public health. ACS Bio Med Chem Au. 2023;3(2):137–146. doi: 10.1021/acsbiomedchemau.2c00055.</cite> [<a href="https://doi.org/10.1021/acsbiomedchemau.2c00055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10125384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37101810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Bio%20Med%20Chem%20Au&amp;title=Antifungal%20development%20and%20the%20urgency%20of%20minimizing%20the%20impact%20of%20fungal%20diseases%20on%20public%20health&amp;author=H.%20C.%20de%20Oliveira&amp;author=B.%20T.%20Bezerra&amp;author=M.%20L.%20Rodrigues&amp;volume=3&amp;issue=2&amp;publication_year=2023&amp;pages=137-146&amp;pmid=37101810&amp;doi=10.1021/acsbiomedchemau.2c00055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref68">
<cite>Schmidt C.. Fungal diseases
are spreading undetected. Nature. 2024 doi: 10.1038/d41586-024-00751-z.</cite> [<a href="https://doi.org/10.1038/d41586-024-00751-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38485825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Fungal%20diseases%20are%20spreading%20undetected&amp;author=C.%20Schmidt&amp;publication_year=2024&amp;pmid=38485825&amp;doi=10.1038/d41586-024-00751-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref69">
<cite>Belanger E. S., Yang E., Forrest G. N.. Combination
antifungal therapy: When,
where, and why. Curr. Clin. Microbiol. Rep. 2015;2:67–75. doi: 10.1007/s40588-015-0017-z.</cite> [<a href="https://doi.org/10.1007/s40588-015-0017-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Clin.%20Microbiol.%20Rep.&amp;title=Combination%20antifungal%20therapy:%20When,%20where,%20and%20why&amp;author=E.%20S.%20Belanger&amp;author=E.%20Yang&amp;author=G.%20N.%20Forrest&amp;volume=2&amp;publication_year=2015&amp;pages=67-75&amp;doi=10.1007/s40588-015-0017-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref70">
<cite>Zhang Q., Liu F., Zeng M., Mao Y., Song Z.. Drug repurposing strategies
in the development of potential antifungal agents. Appl. Microbiol. Biotechnol. 2021;105(13):5259–5279. doi: 10.1007/s00253-021-11407-7.</cite> [<a href="https://doi.org/10.1007/s00253-021-11407-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8214983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34151414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Appl.%20Microbiol.%20Biotechnol.&amp;title=Drug%20repurposing%20strategies%20in%20the%20development%20of%20potential%20antifungal%20agents&amp;author=Q.%20Zhang&amp;author=F.%20Liu&amp;author=M.%20Zeng&amp;author=Y.%20Mao&amp;author=Z.%20Song&amp;volume=105&amp;issue=13&amp;publication_year=2021&amp;pages=5259-5279&amp;pmid=34151414&amp;doi=10.1007/s00253-021-11407-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref71">
<cite>Ivanov M., Ćirić A., Stojković D.. Emerging antifungal targets and strategies. Int. J. Mol. Sci. 2022;23(5):2756. doi: 10.3390/ijms23052756.</cite> [<a href="https://doi.org/10.3390/ijms23052756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8911111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35269898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Emerging%20antifungal%20targets%20and%20strategies&amp;author=M.%20Ivanov&amp;author=A.%20%C4%86iri%C4%87&amp;author=D.%20Stojkovi%C4%87&amp;volume=23&amp;issue=5&amp;publication_year=2022&amp;pages=2756&amp;pmid=35269898&amp;doi=10.3390/ijms23052756&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref72">
<cite>Zhu P., Li Y., Guo T., Liu S., Tancer R. J., Hu C., Zhao C., Xue C., Liao G.. New antifungal strategies:
Drug combination and co-delivery. Adv. Drug
Delivery Rev. 2023;198:114874.  doi: 10.1016/j.addr.2023.114874.</cite> [<a href="https://doi.org/10.1016/j.addr.2023.114874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37211279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Drug%20Delivery%20Rev.&amp;title=New%20antifungal%20strategies:%20Drug%20combination%20and%20co-delivery&amp;author=P.%20Zhu&amp;author=Y.%20Li&amp;author=T.%20Guo&amp;author=S.%20Liu&amp;author=R.%20J.%20Tancer&amp;volume=198&amp;publication_year=2023&amp;pages=114874&amp;pmid=37211279&amp;doi=10.1016/j.addr.2023.114874&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref73">
<cite>Campitelli M., Zeineddine N., Samaha G., Maslak S.. Combination
antifungal
therapy: A review of current data. J. Clin.
Med. Res. 2017;9(6):451–456. doi: 10.14740/jocmr2992w.</cite> [<a href="https://doi.org/10.14740/jocmr2992w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5412516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28496543/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.%20Res.&amp;title=Combination%20antifungal%20therapy:%20A%20review%20of%20current%20data&amp;author=M.%20Campitelli&amp;author=N.%20Zeineddine&amp;author=G.%20Samaha&amp;author=S.%20Maslak&amp;volume=9&amp;issue=6&amp;publication_year=2017&amp;pages=451-456&amp;pmid=28496543&amp;doi=10.14740/jocmr2992w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref74">
<cite>Kim J. H., Cheng L. W., Chan K. L., Tam C. C., Mahoney N., Friedman M., Shilman M. M., Land K. M.. Antifungal drug
repurposing. Antibiotics. 2020;9(11):812. doi: 10.3390/antibiotics9110812.</cite> [<a href="https://doi.org/10.3390/antibiotics9110812" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7697925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33203147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antibiotics&amp;title=Antifungal%20drug%20repurposing&amp;author=J.%20H.%20Kim&amp;author=L.%20W.%20Cheng&amp;author=K.%20L.%20Chan&amp;author=C.%20C.%20Tam&amp;author=N.%20Mahoney&amp;volume=9&amp;issue=11&amp;publication_year=2020&amp;pages=812&amp;pmid=33203147&amp;doi=10.3390/antibiotics9110812&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref75">
<cite>Nicola A. M., Albuquerque P., Paes H. C., Fernandes L., Costa F. F., Kioshima E. S., Abadio A. K. R., Bocca A. L., Felipe M. S.. Antifungal drugs:
New insights in research &amp; development. Pharmacol. Ther. 2019;195:21–38. doi: 10.1016/j.pharmthera.2018.10.008.</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2018.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30347212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol.%20Ther.&amp;title=Antifungal%20drugs:%20New%20insights%20in%20research%20&amp;%20development&amp;author=A.%20M.%20Nicola&amp;author=P.%20Albuquerque&amp;author=H.%20C.%20Paes&amp;author=L.%20Fernandes&amp;author=F.%20F.%20Costa&amp;volume=195&amp;publication_year=2019&amp;pages=21-38&amp;pmid=30347212&amp;doi=10.1016/j.pharmthera.2018.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref76">
<cite>Vanzolini T., Magnani M.. Old and new strategies
in therapy and diagnosis against
fungal infections. Appl. Microbiol. Biotechnol. 2024;108(1):147.  doi: 10.1007/s00253-023-12884-8.</cite> [<a href="https://doi.org/10.1007/s00253-023-12884-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10799149/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38240822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Appl.%20Microbiol.%20Biotechnol.&amp;title=Old%20and%20new%20strategies%20in%20therapy%20and%20diagnosis%20against%20fungal%20infections&amp;author=T.%20Vanzolini&amp;author=M.%20Magnani&amp;volume=108&amp;issue=1&amp;publication_year=2024&amp;pages=147&amp;pmid=38240822&amp;doi=10.1007/s00253-023-12884-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref77">
<cite>Pfaller M. A., Messer S. A., Georgopapadakou N., Martell L. A., Besterman J. M., Diekema D. J.. Activity of MGCD290,
a Hos2 histone deacetylase inhibitor,
in combination with azole antifungals against opportunistic fungal
pathogens. J. Clin. Microbiol. 2009;47(12):3797–3804. doi: 10.1128/JCM.00618-09.</cite> [<a href="https://doi.org/10.1128/JCM.00618-09" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2786684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19794038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Microbiol.&amp;title=Activity%20of%20MGCD290,%20a%20Hos2%20histone%20deacetylase%20inhibitor,%20in%20combination%20with%20azole%20antifungals%20against%20opportunistic%20fungal%20pathogens&amp;author=M.%20A.%20Pfaller&amp;author=S.%20A.%20Messer&amp;author=N.%20Georgopapadakou&amp;author=L.%20A.%20Martell&amp;author=J.%20M.%20Besterman&amp;volume=47&amp;issue=12&amp;publication_year=2009&amp;pages=3797-3804&amp;pmid=19794038&amp;doi=10.1128/JCM.00618-09&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref78">
<cite>Shaw K. J., Ibrahim A. S.. Fosmanogepix: A review of the first-in-class broad
spectrum agent for the treatment of invasive fungal infections. J. Fungi. 2020;6(4):239. doi: 10.3390/jof6040239.</cite> [<a href="https://doi.org/10.3390/jof6040239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7711534/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33105672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Fosmanogepix:%20A%20review%20of%20the%20first-in-class%20broad%20spectrum%20agent%20for%20the%20treatment%20of%20invasive%20fungal%20infections&amp;author=K.%20J.%20Shaw&amp;author=A.%20S.%20Ibrahim&amp;volume=6&amp;issue=4&amp;publication_year=2020&amp;pages=239&amp;pmid=33105672&amp;doi=10.3390/jof6040239&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref79">
<cite>Wiederhold N. P.. Review
of the novel investigational antifungal olorofim. J. Fungi. 2020;6(3):122. doi: 10.3390/jof6030122.</cite> [<a href="https://doi.org/10.3390/jof6030122" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7557671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32751765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Review%20of%20the%20novel%20investigational%20antifungal%20olorofim&amp;author=N.%20P.%20Wiederhold&amp;volume=6&amp;issue=3&amp;publication_year=2020&amp;pages=122&amp;pmid=32751765&amp;doi=10.3390/jof6030122&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref80">
<cite>Aigner M., Lass-Flörl C.. Encochleated
amphotericin B: Is the oral availability
of amphotericin B finally reached? J. Fungi. 2020;6(2):66. doi: 10.3390/jof6020066.</cite> [<a href="https://doi.org/10.3390/jof6020066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7344640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32443486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Encochleated%20amphotericin%20B:%20Is%20the%20oral%20availability%20of%20amphotericin%20B%20finally%20reached?&amp;author=M.%20Aigner&amp;author=C.%20Lass-Fl%C3%B6rl&amp;volume=6&amp;issue=2&amp;publication_year=2020&amp;pages=66&amp;pmid=32443486&amp;doi=10.3390/jof6020066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref81">
<cite>Sun N., Xie Y., Sheng C., Cao Y., Zhang W., Chen H., Fan G.. 
In vivo pharmacokinetics and in vitro antifungal activity
of iodiconazole, a new triazole, determined
by microdialysis sampling. Int. J. Antimicrob.
Agents. 2013;41(3):229–235. doi: 10.1016/j.ijantimicag.2012.10.020.</cite> [<a href="https://doi.org/10.1016/j.ijantimicag.2012.10.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23298433/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Antimicrob.%20Agents&amp;title=In%20vivo%20pharmacokinetics%20and%20in%20vitro%20antifungal%20activity%20of%20iodiconazole,%20a%20new%20triazole,%20determined%20by%20microdialysis%20sampling&amp;author=N.%20Sun&amp;author=Y.%20Xie&amp;author=C.%20Sheng&amp;author=Y.%20Cao&amp;author=W.%20Zhang&amp;volume=41&amp;issue=3&amp;publication_year=2013&amp;pages=229-235&amp;pmid=23298433&amp;doi=10.1016/j.ijantimicag.2012.10.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref82">
<cite>Pathakumari B., Liang G., Liu W.. Immune defence
to invasive fungal
infections: A comprehensive review. Biomed.
Pharmacother. 2020;130:110550.  doi: 10.1016/j.biopha.2020.110550.</cite> [<a href="https://doi.org/10.1016/j.biopha.2020.110550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32739740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed.%20Pharmacother.&amp;title=Immune%20defence%20to%20invasive%20fungal%20infections:%20A%20comprehensive%20review&amp;author=B.%20Pathakumari&amp;author=G.%20Liang&amp;author=W.%20Liu&amp;volume=130&amp;publication_year=2020&amp;pages=110550&amp;pmid=32739740&amp;doi=10.1016/j.biopha.2020.110550&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref83">
<cite>Fernández
de Ullivarri M., Arbulu S., Garcia-Gutierrez E., Cotter P. D.. Antifungal peptides as therapeutic agents. Front. Cell. Infect. Microbiol. 2020;10:105.  doi: 10.3389/fcimb.2020.00105.</cite> [<a href="https://doi.org/10.3389/fcimb.2020.00105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7089922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32257965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell.%20Infect.%20Microbiol.&amp;title=Antifungal%20peptides%20as%20therapeutic%20agents&amp;author=M.%20Fern%C3%A1ndez%20de%20Ullivarri&amp;author=S.%20Arbulu&amp;author=E.%20Garcia-Gutierrez&amp;author=P.%20D.%20Cotter&amp;volume=10&amp;publication_year=2020&amp;pages=105&amp;pmid=32257965&amp;doi=10.3389/fcimb.2020.00105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref84">
<cite>Buda
De Cesare G., Cristy S. A., Garsin D. A., Lorenz M. C.. Antimicrobial
peptides: A new frontier in antifungal therapy. mBio. 2020;11(6):e02123-20.  doi: 10.1128/mBio.02123-20.</cite> [<a href="https://doi.org/10.1128/mBio.02123-20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7642678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33144376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=mBio&amp;title=Antimicrobial%20peptides:%20A%20new%20frontier%20in%20antifungal%20therapy&amp;author=G.%20Buda%20De%20Cesare&amp;author=S.%20A.%20Cristy&amp;author=D.%20A.%20Garsin&amp;author=M.%20C.%20Lorenz&amp;volume=11&amp;issue=6&amp;publication_year=2020&amp;pages=e02123-20&amp;pmid=33144376&amp;doi=10.1128/mBio.02123-20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref85">
<cite>Li T., Li L., Du F., Sun L., Shi J., Long M., Chen Z.. Activity and
mechanism of action of antifungal peptides from microorganisms:
A review. Molecules. 2021;26(11):3438. doi: 10.3390/molecules26113438.</cite> [<a href="https://doi.org/10.3390/molecules26113438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8201221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34198909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Activity%20and%20mechanism%20of%20action%20of%20antifungal%20peptides%20from%20microorganisms:%20A%20review&amp;author=T.%20Li&amp;author=L.%20Li&amp;author=F.%20Du&amp;author=L.%20Sun&amp;author=J.%20Shi&amp;volume=26&amp;issue=11&amp;publication_year=2021&amp;pages=3438&amp;pmid=34198909&amp;doi=10.3390/molecules26113438&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref86">
<cite>Martínez-Culebras P. V., Gandía M., Garrigues S., Marcos J. F., Manzanares P.. Antifungal
peptides and proteins to control toxigenic fungi and mycotoxin biosynthesis. Int. J. Mol. Sci. 2021;22(24):13261.  doi: 10.3390/ijms222413261.</cite> [<a href="https://doi.org/10.3390/ijms222413261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8703302/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34948059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Antifungal%20peptides%20and%20proteins%20to%20control%20toxigenic%20fungi%20and%20mycotoxin%20biosynthesis&amp;author=P.%20V.%20Mart%C3%ADnez-Culebras&amp;author=M.%20Gand%C3%ADa&amp;author=S.%20Garrigues&amp;author=J.%20F.%20Marcos&amp;author=P.%20Manzanares&amp;volume=22&amp;issue=24&amp;publication_year=2021&amp;pages=13261&amp;pmid=34948059&amp;doi=10.3390/ijms222413261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref87">
<cite>Struyfs C., Cammue B. P. A., Thevissen K.. Membrane-interacting
antifungal peptides. Front. Cell. Dev. Biol. 2021;9:649875.  doi: 10.3389/fcell.2021.649875.</cite> [<a href="https://doi.org/10.3389/fcell.2021.649875" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8074791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33912564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell.%20Dev.%20Biol.&amp;title=Membrane-interacting%20antifungal%20peptides&amp;author=C.%20Struyfs&amp;author=B.%20P.%20A.%20Cammue&amp;author=K.%20Thevissen&amp;volume=9&amp;publication_year=2021&amp;pages=649875&amp;pmid=33912564&amp;doi=10.3389/fcell.2021.649875&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref88">
<cite>Pimienta D. A., Cruz Mosquera F. E., Palacios Velasco I., Giraldo Rodas M., Oñate-Garzón J., Liscano Y.. Specific focus on antifungal
peptides against Azole resistant Aspergillus fumigatus: Current status, challenges, and future perspectives. J. Fungi. 2023;9(1):42. doi: 10.3390/jof9010042.</cite> [<a href="https://doi.org/10.3390/jof9010042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9864941/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36675863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Fungi&amp;title=Specific%20focus%20on%20antifungal%20peptides%20against%20Azole%20resistant%20Aspergillus%20fumigatus:%20Current%20status,%20challenges,%20and%20future%20perspectives&amp;author=D.%20A.%20Pimienta&amp;author=F.%20E.%20Cruz%20Mosquera&amp;author=I.%20Palacios%20Velasco&amp;author=M.%20Giraldo%20Rodas&amp;author=J.%20O%C3%B1ate-Garz%C3%B3n&amp;volume=9&amp;issue=1&amp;publication_year=2023&amp;pages=42&amp;pmid=36675863&amp;doi=10.3390/jof9010042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref89">
<cite>Konakbayeva D., Karlsson A. J.. Strategies and opportunities for engineering antifungal
peptides for therapeutic applications. Curr.
Opin. Biotechnol. 2023;81:102926.  doi: 10.1016/j.copbio.2023.102926.</cite> [<a href="https://doi.org/10.1016/j.copbio.2023.102926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10229436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37028003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Opin.%20Biotechnol.&amp;title=Strategies%20and%20opportunities%20for%20engineering%20antifungal%20peptides%20for%20therapeutic%20applications&amp;author=D.%20Konakbayeva&amp;author=A.%20J.%20Karlsson&amp;volume=81&amp;publication_year=2023&amp;pages=102926&amp;pmid=37028003&amp;doi=10.1016/j.copbio.2023.102926&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref90">
<cite>Rodríguez-Castaño G. P., Rosenau F., Ständker L., Firacative C.. Antimicrobial
peptides: Avant-garde antifungal gents to fight against medically
important Candida species. Pharmaceutics. 2023;15(3):789. doi: 10.3390/pharmaceutics15030789.</cite> [<a href="https://doi.org/10.3390/pharmaceutics15030789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10053530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36986650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Antimicrobial%20peptides:%20Avant-garde%20antifungal%20gents%20to%20fight%20against%20medically%20important%20Candida%20species&amp;author=G.%20P.%20Rodr%C3%ADguez-Casta%C3%B1o&amp;author=F.%20Rosenau&amp;author=L.%20St%C3%A4ndker&amp;author=C.%20Firacative&amp;volume=15&amp;issue=3&amp;publication_year=2023&amp;pages=789&amp;pmid=36986650&amp;doi=10.3390/pharmaceutics15030789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref91">
<cite>Oshiro K. G. N., Rodrigues G., Monges B. E. D., Cardoso M. H., Franco O. L.. Bioactive
peptides against fungal biofilms. Front. Microbiol. 2019;10:2169.  doi: 10.3389/fmicb.2019.02169.</cite> [<a href="https://doi.org/10.3389/fmicb.2019.02169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6797862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31681179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Microbiol.&amp;title=Bioactive%20peptides%20against%20fungal%20biofilms&amp;author=K.%20G.%20N.%20Oshiro&amp;author=G.%20Rodrigues&amp;author=B.%20E.%20D.%20Monges&amp;author=M.%20H.%20Cardoso&amp;author=O.%20L.%20Franco&amp;volume=10&amp;publication_year=2019&amp;pages=2169&amp;pmid=31681179&amp;doi=10.3389/fmicb.2019.02169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref92">
<cite>Li Y., Qiao Y., Ma Y., Xue P., Ding C.. AI in fungal
drug development: opportunities, challenges, and future outlook. Front. Cell. Infect. Microbiol. 2025;15:1610743.  doi: 10.3389/fcimb.2025.1610743.</cite> [<a href="https://doi.org/10.3389/fcimb.2025.1610743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12134069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40470259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Cell.%20Infect.%20Microbiol.&amp;title=AI%20in%20fungal%20drug%20development:%20opportunities,%20challenges,%20and%20future%20outlook&amp;author=Y.%20Li&amp;author=Y.%20Qiao&amp;author=Y.%20Ma&amp;author=P.%20Xue&amp;author=C.%20Ding&amp;volume=15&amp;publication_year=2025&amp;pages=1610743&amp;pmid=40470259&amp;doi=10.3389/fcimb.2025.1610743&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref93">
<cite>Lamberth C.. Latest research
trends in agrochemical fungicides: Any learnings for pharmaceutical
antifungals? ACS Med. Chem. Lett. 2022;13(6):895–903. doi: 10.1021/acsmedchemlett.2c00113.</cite> [<a href="https://doi.org/10.1021/acsmedchemlett.2c00113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9190031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35707143/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Latest%20research%20trends%20in%20agrochemical%20fungicides:%20Any%20learnings%20for%20pharmaceutical%20antifungals?&amp;author=C.%20Lamberth&amp;volume=13&amp;issue=6&amp;publication_year=2022&amp;pages=895-903&amp;pmid=35707143&amp;doi=10.1021/acsmedchemlett.2c00113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref94">
<cite>Marchand P. A.. Evolution
of plant protection active substances in Europe: the disappearance
of chemicals in favour of biocontrol agents. Environ. Sci. Pollut. Res. 2023;30(1):1–17. doi: 10.1007/s11356-022-24057-7.</cite> [<a href="https://doi.org/10.1007/s11356-022-24057-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36378372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ.%20Sci.%20Pollut.%20Res.&amp;title=Evolution%20of%20plant%20protection%20active%20substances%20in%20Europe:%20the%20disappearance%20of%20chemicals%20in%20favour%20of%20biocontrol%20agents&amp;author=P.%20A.%20Marchand&amp;volume=30&amp;issue=1&amp;publication_year=2023&amp;pages=1-17&amp;pmid=36378372&amp;doi=10.1007/s11356-022-24057-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref95">
<cite>Eskola M., Kos G., Elliott C. T., Hajšlová J., Mayar S., Krska R.. Worldwide
contamination of food-crops with mycotoxins: Validity of
the widely cited ’FAO estimate’ of 25% Crit. Rev. Food Sci. Nutr. 2020;60(16):2773–2789. doi: 10.1080/10408398.2019.1658570.</cite> [<a href="https://doi.org/10.1080/10408398.2019.1658570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31478403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit.%20Rev.%20Food%20Sci.%20Nutr.&amp;title=Worldwide%20contamination%20of%20food-crops%20with%20mycotoxins:%20Validity%20of%20the%20widely%20cited%20%E2%80%99FAO%20estimate%E2%80%99%20of%2025%&amp;author=M.%20Eskola&amp;author=G.%20Kos&amp;author=C.%20T.%20Elliott&amp;author=J.%20Haj%C5%A1lov%C3%A1&amp;author=S.%20Mayar&amp;volume=60&amp;issue=16&amp;publication_year=2020&amp;pages=2773-2789&amp;pmid=31478403&amp;doi=10.1080/10408398.2019.1658570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref96">
<cite>Gikas G. D., Parlakidis P., Mavropoulos T., Vryzas Z.. Particularities of
fungicides and factors affecting their fate and removal efficacy:
A review. Sustainability. 2022;14(7):4056. doi: 10.3390/su14074056.</cite> [<a href="https://doi.org/10.3390/su14074056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sustainability&amp;title=Particularities%20of%20fungicides%20and%20factors%20affecting%20their%20fate%20and%20removal%20efficacy:%20A%20review&amp;author=G.%20D.%20Gikas&amp;author=P.%20Parlakidis&amp;author=T.%20Mavropoulos&amp;author=Z.%20Vryzas&amp;volume=14&amp;issue=7&amp;publication_year=2022&amp;pages=4056&amp;doi=10.3390/su14074056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref97">
<cite>Davies C. R., Wohlgemuth F., Young T., Violet J., Dickinson M., Sanders J. W., Vallieres C., Avery S. V.. Evolving challenges
and strategies for fungal control in the food supply chain. Fungal Biol. Rev. 2021;36:15–26. doi: 10.1016/j.fbr.2021.01.003.</cite> [<a href="https://doi.org/10.1016/j.fbr.2021.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8127832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34084209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fungal%20Biol.%20Rev.&amp;title=Evolving%20challenges%20and%20strategies%20for%20fungal%20control%20in%20the%20food%20supply%20chain&amp;author=C.%20R.%20Davies&amp;author=F.%20Wohlgemuth&amp;author=T.%20Young&amp;author=J.%20Violet&amp;author=M.%20Dickinson&amp;volume=36&amp;publication_year=2021&amp;pages=15-26&amp;pmid=34084209&amp;doi=10.1016/j.fbr.2021.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref98">
<cite>Corkley I., Fraaije B., Hawkins N.. Fungicide resistance
management:
Maximizing the effective life of plant protection products. Plant Pathol. 2022;71:150–169. doi: 10.1111/ppa.13467.</cite> [<a href="https://doi.org/10.1111/ppa.13467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Plant%20Pathol.&amp;title=Fungicide%20resistance%20management:%20Maximizing%20the%20effective%20life%20of%20plant%20protection%20products&amp;author=I.%20Corkley&amp;author=B.%20Fraaije&amp;author=N.%20Hawkins&amp;volume=71&amp;publication_year=2022&amp;pages=150-169&amp;doi=10.1111/ppa.13467&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref99">
<cite>Van
der Fels-Klerx H. J., Liu C., Battilani P.. Modelling
climate change impacts on mycotoxin contamination. World Mycotoxin J. 2016;9(5):717–726. doi: 10.3920/WMJ2016.2066.</cite> [<a href="https://doi.org/10.3920/WMJ2016.2066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Mycotoxin%20J.&amp;title=Modelling%20climate%20change%20impacts%20on%20mycotoxin%20contamination&amp;author=H.%20J.%20Van%20der%20Fels-Klerx&amp;author=C.%20Liu&amp;author=P.%20Battilani&amp;volume=9&amp;issue=5&amp;publication_year=2016&amp;pages=717-726&amp;doi=10.3920/WMJ2016.2066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref100">
<cite>Singh B. K., Delgado-Baquerizo M., Egidi E., Guirado E., Leach J. E., Liu H., Trivedi P.. Climate change impacts
on plant pathogens, food security and paths forward. Nat. Rev. Microbiol. 2023;21(10):640–656. doi: 10.1038/s41579-023-00900-7.</cite> [<a href="https://doi.org/10.1038/s41579-023-00900-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10153038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37131070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Microbiol.&amp;title=Climate%20change%20impacts%20on%20plant%20pathogens,%20food%20security%20and%20paths%20forward&amp;author=B.%20K.%20Singh&amp;author=M.%20Delgado-Baquerizo&amp;author=E.%20Egidi&amp;author=E.%20Guirado&amp;author=J.%20E.%20Leach&amp;volume=21&amp;issue=10&amp;publication_year=2023&amp;pages=640-656&amp;pmid=37131070&amp;doi=10.1038/s41579-023-00900-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref101">
<cite>Casu A., Camardo Leggieri M., Toscano P., Battilani P.. Changing climate,
shifting mycotoxins: A comprehensive review of climate change impact
on mycotoxin contamination. Compr. Rev. Food
Sci. Food Saf. 2024;23(2):e13323.  doi: 10.1111/1541-4337.13323.</cite> [<a href="https://doi.org/10.1111/1541-4337.13323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38477222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Compr.%20Rev.%20Food%20Sci.%20Food%20Saf.&amp;title=Changing%20climate,%20shifting%20mycotoxins:%20A%20comprehensive%20review%20of%20climate%20change%20impact%20on%20mycotoxin%20contamination&amp;author=A.%20Casu&amp;author=M.%20Camardo%20Leggieri&amp;author=P.%20Toscano&amp;author=P.%20Battilani&amp;volume=23&amp;issue=2&amp;publication_year=2024&amp;pages=e13323&amp;pmid=38477222&amp;doi=10.1111/1541-4337.13323&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref102">
<cite>Hawkins N. J., Fraaije B. A.. Fitness penalties in the evolution
of fungicide resistance. Annu. Rev. Phytopathol. 2018;56:339–360. doi: 10.1146/annurev-phyto-080417-050012.</cite> [<a href="https://doi.org/10.1146/annurev-phyto-080417-050012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29958074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Phytopathol.&amp;title=Fitness%20penalties%20in%20the%20evolution%20of%20fungicide%20resistance&amp;author=N.%20J.%20Hawkins&amp;author=B.%20A.%20Fraaije&amp;volume=56&amp;publication_year=2018&amp;pages=339-360&amp;pmid=29958074&amp;doi=10.1146/annurev-phyto-080417-050012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref103">
<cite>Vande Zande P., Zhou X., Selmecki A.. The dynamic
fungal
genome: Polyploidy, aneuploidy and copy number variation in response
to stress. Annu. Rev. Microbiol. 2023;77:341–361. doi: 10.1146/annurev-micro-041320-112443.</cite> [<a href="https://doi.org/10.1146/annurev-micro-041320-112443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10599402/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37307856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Microbiol.&amp;title=The%20dynamic%20fungal%20genome:%20Polyploidy,%20aneuploidy%20and%20copy%20number%20variation%20in%20response%20to%20stress&amp;author=P.%20Vande%20Zande&amp;author=X.%20Zhou&amp;author=A.%20Selmecki&amp;volume=77&amp;publication_year=2023&amp;pages=341-361&amp;pmid=37307856&amp;doi=10.1146/annurev-micro-041320-112443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref104">
<cite>Zubrod J. P., Bundschuh M., Arts G., Brühl C. A., Imfeld G., Knäbel A., Payraudeau S., Rasmussen J. J., Rohr J., Scharmüller A., Smalling K., Stehle S., Schulz R., Schäfer R. B.. Fungicides:
An overlooked pesticide class? Environ. Sci.
Technol. 2019;53(7):3347–3365. doi: 10.1021/acs.est.8b04392.</cite> [<a href="https://doi.org/10.1021/acs.est.8b04392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6536136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30835448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Environ.%20Sci.%20Technol.&amp;title=Fungicides:%20An%20overlooked%20pesticide%20class?&amp;author=J.%20P.%20Zubrod&amp;author=M.%20Bundschuh&amp;author=G.%20Arts&amp;author=C.%20A.%20Br%C3%BChl&amp;author=G.%20Imfeld&amp;volume=53&amp;issue=7&amp;publication_year=2019&amp;pages=3347-3365&amp;pmid=30835448&amp;doi=10.1021/acs.est.8b04392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref105">
<cite>

Robertson, R.
; 
Wentworth, J.
. 
Understanding Insect
Decline: Data and Driver, UK Parliament POST-Parliamentary
Office of Science and Technology; 
2020.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Understanding%20Insect%20Decline:%20Data%20and%20Driver&amp;publication_year=2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref106">
<cite>
European Environment Agency . How Pesticides Impact Human Health and Ecosystems
in Europe, European Environment Agency, 2023.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=How%20Pesticides%20Impact%20Human%20Health%20and%20Ecosystems%20in%20Europe&amp;publication_year=2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref107">
<cite>Thind T.
S.. Changing trends in discovery
of new fungicides: a perspective. Indian Phytopathol. 2021;74:875–883. doi: 10.1007/s42360-021-00411-6.</cite> [<a href="https://doi.org/10.1007/s42360-021-00411-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Phytopathol.&amp;title=Changing%20trends%20in%20discovery%20of%20new%20fungicides:%20a%20perspective&amp;author=T.%20S.%20Thind&amp;volume=74&amp;publication_year=2021&amp;pages=875-883&amp;doi=10.1007/s42360-021-00411-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref108">
<cite>Ishii H.. New chemical fungicides in relation
to risk for resistance development. Trop. Plant
Pathol. 2024;49:18–35. doi: 10.1007/s40858-023-00596-3.</cite> [<a href="https://doi.org/10.1007/s40858-023-00596-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trop.%20Plant%20Pathol.&amp;title=New%20chemical%20fungicides%20in%20relation%20to%20risk%20for%20resistance%20development&amp;author=H.%20Ishii&amp;volume=49&amp;publication_year=2024&amp;pages=18-35&amp;doi=10.1007/s40858-023-00596-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref109">
<cite>Palmieri D., Ianiri G., Del Grosso C., Barone G., De Curtis F., Castoria R., Lima G.. Advances and
perspectives in the ise of biocontrol agents against fungal plant
diseases. Horticulturae. 2022;8:577. doi: 10.3390/horticulturae8070577.</cite> [<a href="https://doi.org/10.3390/horticulturae8070577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Horticulturae&amp;title=Advances%20and%20perspectives%20in%20the%20ise%20of%20biocontrol%20agents%20against%20fungal%20plant%20diseases&amp;author=D.%20Palmieri&amp;author=G.%20Ianiri&amp;author=C.%20Del%20Grosso&amp;author=G.%20Barone&amp;author=F.%20De%20Curtis&amp;volume=8&amp;publication_year=2022&amp;pages=577&amp;doi=10.3390/horticulturae8070577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref110">
<cite>Schmaltz S., Silva M. A., Ninaus R. G., Guedes J. V. C., Zabot G. L., Tres M. V., Mazutti M. A.. Biomolecules in
modern and sustainable agriculture. 3 Biotech. 2023;13(2):70.  doi: 10.1007/s13205-023-03486-2.</cite> [<a href="https://doi.org/10.1007/s13205-023-03486-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9889597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36742447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=3%20Biotech&amp;title=Biomolecules%20in%20modern%20and%20sustainable%20agriculture&amp;author=S.%20Schmaltz&amp;author=M.%20A.%20Silva&amp;author=R.%20G.%20Ninaus&amp;author=J.%20V.%20C.%20Guedes&amp;author=G.%20L.%20Zabot&amp;volume=13&amp;issue=2&amp;publication_year=2023&amp;pages=70&amp;pmid=36742447&amp;doi=10.1007/s13205-023-03486-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref111">
<cite>Deresa E. M., Diriba T. F.. Phytochemicals as
alternative fungicides
for controlling plant diseases: A comprehensive review of their efficacy,
commercial representatives, advantages, challenges for adoption, and
possible solutions. Heliyon. 2023;9(3):e13810.  doi: 10.1016/j.heliyon.2023.e13810.</cite> [<a href="https://doi.org/10.1016/j.heliyon.2023.e13810" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9984788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36879959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=Phytochemicals%20as%20alternative%20fungicides%20for%20controlling%20plant%20diseases:%20A%20comprehensive%20review%20of%20their%20efficacy,%20commercial%20representatives,%20advantages,%20challenges%20for%20adoption,%20and%20possible%20solutions&amp;author=E.%20M.%20Deresa&amp;author=T.%20F.%20Diriba&amp;volume=9&amp;issue=3&amp;publication_year=2023&amp;pages=e13810&amp;pmid=36879959&amp;doi=10.1016/j.heliyon.2023.e13810&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref112">
<cite>Rosa S., Pesaresi P., Mizzotti C., Bulone V., Mezzetti B., Baraldi E., Masiero S.. Game-changing
alternatives
to conventional fungicides: small RNAs and short peptides. Trends Biotechnol. 2022;40(3):320–337. doi: 10.1016/j.tibtech.2021.07.003.</cite> [<a href="https://doi.org/10.1016/j.tibtech.2021.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34489105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Biotechnol.&amp;title=Game-changing%20alternatives%20to%20conventional%20fungicides:%20small%20RNAs%20and%20short%20peptides&amp;author=S.%20Rosa&amp;author=P.%20Pesaresi&amp;author=C.%20Mizzotti&amp;author=V.%20Bulone&amp;author=B.%20Mezzetti&amp;volume=40&amp;issue=3&amp;publication_year=2022&amp;pages=320-337&amp;pmid=34489105&amp;doi=10.1016/j.tibtech.2021.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref113">
<cite>Thery T., Lynch K. M., Arendt E. K.. Natural
antifungal
peptides/proteins as model for novel food preservatives. Compr. Rev. Food Sci. Food Saf. 2019;18(5):1327–1360. doi: 10.1111/1541-4337.12480.</cite> [<a href="https://doi.org/10.1111/1541-4337.12480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33336909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Compr.%20Rev.%20Food%20Sci.%20Food%20Saf.&amp;title=Natural%20antifungal%20peptides/proteins%20as%20model%20for%20novel%20food%20preservatives&amp;author=T.%20Thery&amp;author=K.%20M.%20Lynch&amp;author=E.%20K.%20Arendt&amp;volume=18&amp;issue=5&amp;publication_year=2019&amp;pages=1327-1360&amp;pmid=33336909&amp;doi=10.1111/1541-4337.12480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref114">
<cite>Tang R., Tan H., Dai Y., Li L., Huang Y., Yao H., Cai Y., Yu G.. Application
of antimicrobial peptides in plant protection: making use of the overlooked
merits. Front. Plant Sci. 2023;14:1139539.  doi: 10.3389/fpls.2023.1139539.</cite> [<a href="https://doi.org/10.3389/fpls.2023.1139539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10394246/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37538059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Plant%20Sci.&amp;title=Application%20of%20antimicrobial%20peptides%20in%20plant%20protection:%20making%20use%20of%20the%20overlooked%20merits&amp;author=R.%20Tang&amp;author=H.%20Tan&amp;author=Y.%20Dai&amp;author=L.%20Li&amp;author=Y.%20Huang&amp;volume=14&amp;publication_year=2023&amp;pages=1139539&amp;pmid=37538059&amp;doi=10.3389/fpls.2023.1139539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref115">
<cite>Tagliabue G.. The EU legislation on ″GMOs″ between
nonsense and protectionism: An ongoing Schumpeterian chain of public
choices. GM Crops Food. 2017;8(1):57–73. doi: 10.1080/21645698.2016.1270488.</cite> [<a href="https://doi.org/10.1080/21645698.2016.1270488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5592980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28001470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=GM%20Crops%20Food&amp;title=The%20EU%20legislation%20on%20%E2%80%B3GMOs%E2%80%B3%20between%20nonsense%20and%20protectionism:%20An%20ongoing%20Schumpeterian%20chain%20of%20public%20choices&amp;author=G.%20Tagliabue&amp;volume=8&amp;issue=1&amp;publication_year=2017&amp;pages=57-73&amp;pmid=28001470&amp;doi=10.1080/21645698.2016.1270488&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref116">
<cite>Lucht J. M.. Public acceptance of plant biotechnology
and GM Crops. Viruses. 2015;7:4254–4281. doi: 10.3390/v7082819.</cite> [<a href="https://doi.org/10.3390/v7082819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4576180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26264020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Viruses&amp;title=Public%20acceptance%20of%20plant%20biotechnology%20and%20GM%20Crops&amp;author=J.%20M.%20Lucht&amp;volume=7&amp;publication_year=2015&amp;pages=4254-4281&amp;pmid=26264020&amp;doi=10.3390/v7082819&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref117">
<cite>Tleuova A. B., Wielogorska E., Talluri V.S.S.L.P., Štěpánek F., Elliott C. T., Grigoriev D. O.. Recent
advances and remaining barriers to producing novel formulations of
fungicides for safe and sustainable agriculture. J. Controlled Release. 2020;326:468–481. doi: 10.1016/j.jconrel.2020.07.035.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2020.07.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32721524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Controlled%20Release&amp;title=Recent%20advances%20and%20remaining%20barriers%20to%20producing%20novel%20formulations%20of%20fungicides%20for%20safe%20and%20sustainable%20agriculture&amp;author=A.%20B.%20Tleuova&amp;author=E.%20Wielogorska&amp;author=V.S.S.L.P.%20Talluri&amp;author=F.%20%C5%A0t%C4%9Bp%C3%A1nek&amp;author=C.%20T.%20Elliott&amp;volume=326&amp;publication_year=2020&amp;pages=468-481&amp;pmid=32721524&amp;doi=10.1016/j.jconrel.2020.07.035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref118">
<cite>Li P., Huang Y., Fu C., Jiang S. X., Peng W., Jia Y., Peng H., Zhang P., Manzie N., Mitter N., Xu Z. P.. Eco-friendly biomolecule-nanomaterial
hybrids as next-generation
agrochemicals for topical delivery. EcoMat. 2021;3(5):e12132.  doi: 10.1002/eom2.12132.</cite> [<a href="https://doi.org/10.1002/eom2.12132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EcoMat&amp;title=Eco-friendly%20biomolecule-nanomaterial%20hybrids%20as%20next-generation%20agrochemicals%20for%20topical%20delivery&amp;author=P.%20Li&amp;author=Y.%20Huang&amp;author=C.%20Fu&amp;author=S.%20X.%20Jiang&amp;author=W.%20Peng&amp;volume=3&amp;issue=5&amp;publication_year=2021&amp;pages=e12132&amp;doi=10.1002/eom2.12132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref119">
<cite>Hardy A., Benford D., Halldorsson T.. EFSA Scientific Committee et al. Guidance on risk assessment of the application of nanoscience
and nanotechnologies in the food and feed chain: part 1, human and
animal health. EFSA J. 2018;16(7):e05327.  doi: 10.2903/j.efsa.2018.5327.</cite> [<a href="https://doi.org/10.2903/j.efsa.2018.5327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7009542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32625968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EFSA%20J.&amp;title=Guidance%20on%20risk%20assessment%20of%20the%20application%20of%20nanoscience%20and%20nanotechnologies%20in%20the%20food%20and%20feed%20chain:%20part%201,%20human%20and%20animal%20health&amp;author=A.%20Hardy&amp;author=D.%20Benford&amp;author=T.%20Halldorsson&amp;volume=16&amp;issue=7&amp;publication_year=2018&amp;pages=e05327&amp;pmid=32625968&amp;doi=10.2903/j.efsa.2018.5327&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref120">
<cite>Head M. G., Fitchett J. R., Atun R., May R. C.. Systematic
analysis of funding awarded for mycology research to institutions
in the UK, 1997–2010. BMJ Open. 2014;4(1):e004129.  doi: 10.1136/bmjopen-2013-004129.</cite> [<a href="https://doi.org/10.1136/bmjopen-2013-004129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3902376/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24413353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=Systematic%20analysis%20of%20funding%20awarded%20for%20mycology%20research%20to%20institutions%20in%20the%20UK,%201997%E2%80%932010&amp;author=M.%20G.%20Head&amp;author=J.%20R.%20Fitchett&amp;author=R.%20Atun&amp;author=R.%20C.%20May&amp;volume=4&amp;issue=1&amp;publication_year=2014&amp;pages=e004129&amp;pmid=24413353&amp;doi=10.1136/bmjopen-2013-004129&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref121">
<cite>Shelton J. M. G., Fisher M. C., Singer A. C.. Campaign-based
citizen
science for environmental mycology: The science solstice and soil-stice
projects to assess drug resistance in air- and soil-borne Aspergillus fumigatus
. Citizen Sci.:
Theory Pract. 2020;5(1):20.  doi: 10.5334/cstp.325.</cite> [<a href="https://doi.org/10.5334/cstp.325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Citizen%20Sci.:%20Theory%20Pract.&amp;title=Campaign-based%20citizen%20science%20for%20environmental%20mycology:%20The%20science%20solstice%20and%20soil-stice%20projects%20to%20assess%20drug%20resistance%20in%20air-%20and%20soil-borne%20Aspergillus%20fumigatus&amp;author=J.%20M.%20G.%20Shelton&amp;author=M.%20C.%20Fisher&amp;author=A.%20C.%20Singer&amp;volume=5&amp;issue=1&amp;publication_year=2020&amp;pages=20&amp;doi=10.5334/cstp.325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref122">
<cite>Shelton J. M. G., Collins R., Uzzell C. B., Alghamdi A., Dyer P. S., Singer A. C., Fisher M. C.. Citizen science
surveillance of triazole-resistant Aspergillus fumigatus in United Kingdom residential garden soils. Appl. Environ. Microbiol. 2022;88(4):e0206121.  doi: 10.1128/aem.02061-21.</cite> [<a href="https://doi.org/10.1128/aem.02061-21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8862786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34986003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Appl.%20Environ.%20Microbiol.&amp;title=Citizen%20science%20surveillance%20of%20triazole-resistant%20Aspergillus%20fumigatus%20in%20United%20Kingdom%20residential%20garden%20soils&amp;author=J.%20M.%20G.%20Shelton&amp;author=R.%20Collins&amp;author=C.%20B.%20Uzzell&amp;author=A.%20Alghamdi&amp;author=P.%20S.%20Dyer&amp;volume=88&amp;issue=4&amp;publication_year=2022&amp;pages=e0206121&amp;pmid=34986003&amp;doi=10.1128/aem.02061-21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref123">
<cite>Olita T., Stankovicm M., Sung B., Jones M., Gibberd M.. Growers’ perceptions and attitudes towards fungicide
resistance extension services. Sci. Rep. 2024;14(1):6821.  doi: 10.1038/s41598-024-57530-z.</cite> [<a href="https://doi.org/10.1038/s41598-024-57530-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10957904/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38514777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Growers%E2%80%99%20perceptions%20and%20attitudes%20towards%20fungicide%20resistance%20extension%20services&amp;author=T.%20Olita&amp;author=M.%20Stankovicm&amp;author=B.%20Sung&amp;author=M.%20Jones&amp;author=M.%20Gibberd&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=6821&amp;pmid=38514777&amp;doi=10.1038/s41598-024-57530-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from ACS Bio &amp; Med Chem Au are provided here courtesy of <strong>American Chemical Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1021/acsbiomedchemau.5c00103"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/bg5c00103.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (10.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371507/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371507/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371507%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371507/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371507/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371507/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371507/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371507/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371507/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="G931s8Bn5iUQ0EMsUlJ4WScPT2Nrb2jPeWjZ6w89JgvQkTUXDGMSdz6us9qS39uD">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
